Aletho News

ΑΛΗΘΩΣ

Historic blow to South Korea’s military intelligence agency

“Military Intervention in Politics Will No Longer Be Possible”

By Erkin Oncan | Strategic Culture Foundation | June 15, 2026

The aftermath of the December 2024 coup attempt in South Korea, led by former President Yoon Suk-yeol, continues to reverberate.

It was revealed that Yoon had ordered drone deployments to North Korea in an effort to escalate tensions and create conditions conducive to a coup. The ongoing trials related to these events have now concluded with prison sentences handed down to Yoon and other senior officials of the era.

The Seoul Central District Court found Yoon guilty of “acts benefiting the enemy” and sentenced him to 30 years in prison. Among those convicted was then–Defense Minister Kim Yong-hyun, who also received a 30-year sentence.

Yeo In-hyung, head of the Armed Forces Counterintelligence Command – one of the most powerful units within the South Korean military – was sentenced to 15 years in prison.

The lightest sentence was given to Kim Yong-dae, then commander of Drone Operations, who was closest to the “obedience within the chain of command” principle. He received a three-year prison sentence, suspended for five years.

These prison sentences represent far more than the punishment of a criminal act. Since the suppression of the coup attempt, Seoul has been undergoing a profound transformation in both military and civilian bureaucracy.

One of the most significant steps in this transformation was taken two days ago.

The South Korean government announced the dissolution of a military intelligence unit under the Ministry of National Defense.

The disbanded institution was the Defense Counterintelligence Command, known by the abbreviation DCC.

The primary justification for the decision was the command’s “role during the martial law process.” However, details of the restructuring also provide important clues about the broader transformation underway within the military.

What was the DCC?

The DCC has a history spanning more than 70 years. Since its establishment in 1950, it has also been known as the “Special Service Unit,” “Security Command,” and “Military Security Command.”

It acquired its current structure in October 1977, when the Army Security Command, Naval Security Unit, and Air Force Special Investigation Office were merged.

Not only the DCC but all of Korea’s intelligence services have played central roles in nearly every dark chapter of the country’s modern history.

One of the most notable examples is the assassination of former President Park Chung-hee in 1979, known as the “October 26 Incident.”

Park, one of Korea’s longest-ruling dictators, was assassinated by Kim Jae-gyu, the then-head of the Korea Central Intelligence Agency (KCIA).

This assassination – rooted largely in inter-agency rivalry – demonstrates how state institutions, particularly intelligence bodies, have historically been capable of reshaping political power dynamics in pursuit of institutional dominance.

At the time, the DCC (then known as the Military Security Command) was a powerful centralized military intelligence organization.

The figure who significantly strengthened the DCC and made it capable of intervening in politics was Chun Doo-hwan, who was appointed head of the organization six months before the assassination.

Chun used investigations under his control to purge rivals and seized power through a military coup in 1979. The subsequent wave of martial law culminated in the bloody suppression of the Gwangju Uprising in 1980.

The Gwangju uprising

The Gwangju Uprising (May 18–20, 1980) began with student protests and rapidly expanded into a broader civilian resistance against military dictatorship.

It was brutally suppressed by military forces, resulting in the deaths of thousands of civilians at the hands of their own army.

Today, it is commemorated every May 18 as one of the most tragic events in Korean history.

During this period, the DCC played a central, if not decisive, role. It is known that its members infiltrated civilian crowds in plain clothes, spread misinformation and rumors, and engaged in various provocations to escalate violence.

Scandals and reorganizations

By the 1990s, the DCC once again came under scrutiny, this time due to illegal surveillance scandals.

Investigations revealed that the organization had built a nationwide illegal monitoring network targeting civilians and politicians alike. These revelations led to another name change in 1991.

In more recent history, the agency was implicated in political interference in 2018. According to reports by Yonhap News Agency at the time, the DCC played a role in disseminating online content supporting the ruling party and targeting opposition figures.

During the latest coup attempt, it was also revealed that the DCC had planned operations to surround key institutions such as parliament, formed arrest teams targeting political opponents, and prepared detention lists.

In short, for a significant portion of the public in South Korea, this quasi–counterintelligence structure – often described as a politicized “dirty security apparatus” – had long been seen as an institution that should have been dismantled years ago.

The dissolution process

This historic development in South Korean politics was announced by Defense Minister Ahn Gyu-back during a press briefing at the ministry.

According to the minister, the new restructuring ensures that “military intervention in politics will no longer be possible.”

Emphasizing that the decision is “not merely an administrative reorganization,” he stated:

“This step is a fundamental restructuring of the structure and mission of military intelligence agencies to ensure they can never again interfere in politics. It marks a historic turning point toward building a military that belongs to the people.”

What is changing?

Under the new arrangement, the DCC will be dismantled and divided.

Its functions – including counterintelligence, defense industry intelligence, security investigations, and security inspections – will be transferred to different institutions.

A newly established Defense Counterintelligence Center will take over counterintelligence operations, defense industry intelligence, defense industrial security, and cybersecurity.

Authorities related to security investigations and joint investigations conducted during martial law periods will be transferred to the Ministry of National Defense’s existing Investigation Headquarters.

Security inspections at corps-level and above units, along with investigations into security violations, will be assigned to a newly created Defense Security Support Group.

At the same time, several key powers that previously enabled the command’s influence within the military are being completely abolished.

From now on, South Korea’s military intelligence agency will no longer be able to monitor military personnel’s activities, collect intelligence on service members, prepare reputation assessments of officers and soldiers, or gather information on corruption and other misconduct outside the scope of counterintelligence.

Strengthening civilian oversight

As the DCC is dismantled, civilian oversight over the newly established Counterintelligence Center is being guaranteed.

The inspector general of the new structure will be a senior civilian auditor. A newly created intelligence and counterintelligence oversight committee within the Ministry of National Defense will operate directly under the defense minister and be composed entirely of civilians.

The government is also working on new legislation that clearly defines the operational limits of military counterintelligence personnel and establishes penalties for illegal activities.

A turning point

The dissolution of the DCC represents more than a simple institutional reorganization. It can also be interpreted as South Korea’s long-delayed confrontation with its history of military coups and military political influence.

Ultimately, however, the extent to which these plans and decisions are successfully implemented will depend once again on the balance of power within both the military and the political establishment.

June 16, 2026 Posted by | Civil Liberties, Deception | , | Comments Off on Historic blow to South Korea’s military intelligence agency

Radio Free Europe, the Cold War ‘Weapon’ Congress Still Funds

By Patrick Pillow | The Libertarian Institute | June 16, 2026

“Radio Free Europe and Radio Liberty were critically important weapons in the free world’s competition with Soviet totalitarianism—and without them the Soviet bloc might even have not disintegrated.”

This was the assessment of Zbigniew Brzezinski, former national security advisor to President Jimmy Carter and one of the most influential foreign policy strategists of the Cold War era.

Brzezinski’s description is notable not only because of who said it, but because of how he described the organization. He did not characterize Radio Free Europe/Radio Liberty as merely a U.S.-funded news organization but instead, referred to it as a “weapon” in a geopolitical struggle between the United States and the Soviet Union.

More than three decades after the Cold War ended, Radio Free Europe/Radio Liberty remains in operation—and Congress is now considering a major increase in its funding.

As Americans continue to grapple with rising prices and persistent inflation, Washington DC’s attention has increasingly shifted toward foreign policy priorities rather than domestic economic concerns. When foreign spending does enter the public conversation, it is often through provisions buried deep within legislative text and only briefly summarized in committee reports, with limited public attention.

One recent example is the Ukraine Support Act, sponsored by Representative Gregory Meeks (D-NY). The bill continues ongoing U.S. funding for Ukraine as the war with Russia enters its fourth year, and like most large foreign aid packages, it contains a wide range of provisions.

Among them is Section 108, which authorizes $250 million in funding for Radio Free Europe/Radio Liberty (RFE/RL) for 2026 alone. The language describes this funding as necessary to bring the organization to its “full capacity” in combating “conspiracy theories” and “Russian disinformation.” To understand this framing, it helps to look at the organization’s origins.

When it was originally founded in the 1950s, Radio Free Europe/Radio Liberty was created to broadcast alternative reporting into countries behind the Iron Curtain. It received its first significant funding from both the U.S. Congress and the Central Intelligence Agency (CIA), and has since been described as one of the CIA’s largest successful covert action projects.

Among the organization’s initial goals was a focus on “destroying the Soviet government’s monopoly of information,” during the Cold War. This included early attempts to create a “crisis of confidence” in Soviet leadership.

Over time, that structure evolved, but the organization remained. Today, Radio Free Europe/Radio Liberty operates in more than twenty countries, with a reported weekly audience of 47.6 million, more than 1,700 staff members, and over 9 billion video views in 2023. Its operations now include Radio Farda in Iran, Radio Azadi in Afghanistan, and services in the Balkans—regions of significant U.S. foreign policy interest.

What was once a Cold War-era broadcasting organization has become a global, publicly funded media operation with a clear geopolitical focus. According to congressional funding records and budget summaries, RFE/RL has received roughly $140–$150 million annually since 2023. The 2026 authorization increases prior funding levels by over 60%, with the stated goal of combating what Washington describes as “disinformation.”

The organization itself is almost entirely publicly funded. In a March 2025 court declaration, RFE/RL president Stephen Capus stated that roughly 99% of the organization’s funding comes from congressional appropriations through the U.S. Agency for Global Media, while around 1% comes from private donations or other sources.

When funding was briefly disrupted in 2025, Capus called the interruption a “massive gift to America’s enemies,” pointing specifically to governments like Russia, China, Iran, and Belarus as among those who would “celebrate the demise” of the organization.

Supporters of RFE/RL note that the relatively small cost—especially compared to overall defense and foreign aid spending—is justified by its strategic value. With independent media remaining a key tool for challenging state-controlled narratives abroad, think tanks such as the Hudson Institute have described RFE/RL funding as a “pittance in terms of U.S. government spending,” with a particular focus on countries like Russia, China, and Iran.

As a whole, RFE/RL sees itself as more than just an independent news organization. In an FAQ section on its website the group notes that the organization is also working to serve U.S. foreign policy objectives and U.S. national security interests.

Still, this leaves unresolved the question about whether communication organizations abroad should be treated as a permanent feature on the domestic spending ledger.

At a time when the U.S. economy continues to face inflationary pressure and the stock market experiences significant volatility, the question remains what tangible benefit U.S. citizens receive from this use of tax dollars.

Whether Radio Free Europe/Radio Liberty is viewed as a valuable instrument of American influence or an outdated relic of the Cold War, Congress is now preparing to increase its funding substantially.

June 16, 2026 Posted by | Deception, Fake News, Mainstream Media, Warmongering | | Comments Off on Radio Free Europe, the Cold War ‘Weapon’ Congress Still Funds

‘Jewish lobby’ deceived Putin – Lukashenko

RT | June 15, 2026

Russian President Vladimir Putin was deceived into withdrawing troops from near Kiev in 2022 by forces claiming to represent Vladimir Zelensky’s willingness to seek peace, Belarusian President Alexander Lukashenko has said.

Speaking in an interview with Al Arabiya, Lukashenko said the conflict could have ended quickly in its early stages, when Moscow’s forces were near the Ukrainian capital.

“At the time, not only I, but everyone in the world understood that the war would end quickly with a Russian victory. This was primarily because the Russians were in Kiev,” the Belarusian leader said, according to BelTA.

However, Lukashenko claimed that “certain politicians and forces” then asked Putin to stop, pull troops back from Kiev, and conclude a peace agreement. “Before that withdrawal, everyone understood that Ukraine’s days were numbered.”

The Belarusian president argued that Moscow had been acting on what appeared to be a genuine opportunity to reach a settlement, adding: “Judge for yourselves who was right and who was wrong in this matter.”

“Once again, probably, these forces deceived him. It was the Vatican. And, surprisingly, the Jewish lobby, the Israelis,” Lukashenko said. “They said on behalf of Zelensky: that’s it, we are moving toward peace, we agree. And others as well.”

It was not immediately clear what exactly Lukashenko meant by the “Jewish lobby.” In the early days of the conflict, then-Israeli Prime Minister Naftali Bennett acted as a mediator between Moscow and Kiev, meeting Putin in Moscow and holding multiple phone calls with Zelensky. Media reports at the time claimed that Bennett had urged Zelensky to accept Moscow’s terms.

Lukashenko also did not elaborate on the Vatican’s alleged role. In March 2022, however, Pope Francis and Russian Orthodox Patriarch Kirill held a video call in which they stressed the “exceptional importance” of the negotiation process.

Moscow and Kiev held several rounds of peace talks in Istanbul in March 2022. Putin said in June 2023 that Ukrainian negotiators had initialed a draft treaty on permanent neutrality and security guarantees, but that Kiev later abandoned the deal after Russian troops pulled back from areas near the Ukrainian capital.

Moscow has argued that Ukraine walked away from the agreement under Western pressure, including from then-British Prime Minister Boris Johnson, who reportedly urged Kiev not to sign any deal with Moscow and to “continue fighting.”

Kiev has disputed Moscow’s account of the failed talks, even though its former chief negotiator, David Arakhamia, has acknowledged Johnson’s role. Ukraine has since formally applied to join NATO and abandoned discussions of neutrality.

June 15, 2026 Posted by | Deception | , , , , | Comments Off on ‘Jewish lobby’ deceived Putin – Lukashenko

The 12 Screenings That Manufacture the Patients They Claim to Find

An Essay on Threshold Manipulation, Overdiagnosis, Cascades, and the Markers That Aren’t What They Claim

Lies are Unbekoming | June 10, 2026

The Pattern Across the Programmes

In 2022, the New England Journal of Medicine published the results of the NordICC trial — the first randomised controlled study of colonoscopy screening ever conducted. Over 84,000 people were followed for ten years. The trial found an 18% reduction in cancer incidence and no significant reduction in cancer deaths. To prevent a single case of colorectal cancer, 455 people had to be invited for screening. To prevent a single death, the numbers were statistically indistinguishable from zero.¹

This is the pattern.

Across the major screening programmes — mammography, PSA, Pap, colonoscopy, lung CT — when the question is whether the screened population actually outlives the unscreened population, the benefit largely disappears.² The statistic the programmes advertise is disease-specific mortality: deaths from the disease the test is looking for. The statistic they bury is all-cause mortality: whether the screened group, taken as a whole, lives longer. The two numbers are not the same. You can reduce deaths from one disease while total deaths remain flat — because treatment has killed as many people as the disease prevented, or because the disease you found was never going to kill anyone.²

The screened do not live longer than the unscreened. They are more likely to spend their remaining years monitored, biopsied, cut, and medicated for conditions that would not have harmed them. This essay catalogues twelve tests that produce that conversion, organised by the four mechanisms through which it is achieved.

The Frame

Five concepts make the rest of this essay readable.

Disease-specific versus all-cause mortality. A screening programme can reduce deaths from breast cancer while total deaths remain unchanged. This happens when treatment kills as many people as the disease — through surgical complications, radiation-induced secondary cancers, cardiovascular effects of chemotherapy, or the cascade of follow-up procedures that screening triggers. Only all-cause mortality reveals whether the programme, taken as a whole, extended life.² Trials that report disease-specific reductions without corresponding all-cause reductions are reporting a redistribution of deaths.

Lead-time bias. A cancer destined to kill at age 70 appears as a three-year survival if found at age 67 through symptoms, and a seven-year survival if found at age 63 through screening. The patient dies at the same age in both cases — the clock simply started earlier. Five-year survival statistics, the most commonly cited evidence for screening success, are inevitably improved by earlier detection, even when no life is extended by a single day.² Kidney cancer five-year survival improved from 50% to 60% as imaging found more small tumours; the death rate from kidney cancer remained unchanged.²

Length bias. Aggressive cancers grow fast, become symptomatic between screening intervals, and reach the patient through the clinic rather than the screening room. Indolent cancers linger for years in the detectable phase, making them easy targets. The cancers screening preferentially catches are the ones least likely to kill. The ones most likely to kill evade it.²

Overdiagnosis, and the autopsy reservoir behind it. Approximately 40–70% of older men have prostate cancer at autopsy, while only about 3% die from it.² Up to 39% of middle-aged women show evidence of breast cancer at autopsy; lifetime risk of dying from it is under 4%.² Thyroid cancer appears in 36–100% of carefully examined autopsies, depending on how many microscope slides the pathologist prepares.² Polyps are found in 32–50% of older adults; only 5% develop colorectal cancer.³ The reservoir of detectable-but-harmless abnormality is vast. Every screening test dips into it. Every person pulled from it becomes a cancer patient who can only be harmed by treatment, because they were never at risk.

The threshold. The cutoff that separates well from sick is set by a committee, not by biology. In every screening category, the threshold has been lowered — by panels whose members hold financial relationships with the manufacturers of the drugs and devices used to treat the redefined condition.⁴ The 1988 cholesterol panel. The 1994 WHO bone density panel.⁵ The 2003 American Diabetes Association threshold for impaired fasting glucose.⁶ The 2017 American College of Cardiology hypertension revision.⁷ The lowered PSA cutoff. Each revision converts millions of well people into patients overnight. No one inside their body changed.

The early-detection objection — that finding disease earlier must, by intuition, help — fails on this evidence. It assumes that everything labelled cancer or pre-cancer will progress; the autopsy data say otherwise. It assumes that finding more is finding harm prevented; the mortality data say otherwise. It assumes that the people setting the thresholds are disinterested; the disclosures say otherwise.


Group A — Threshold Manipulation

The number creates the disease.

The first three screenings illustrate the cleanest mechanism in the catalogue. The cutoff changes while the body does not, and the well become the sick by committee vote. The drug to treat the redefined condition is manufactured by the company whose representative sat on the panel that lowered it.

1. Bone Density (DEXA) and the Manufactured Pre-Disease

In 1994, a World Health Organization panel redefined osteoporosis based on bone mineral density measured by DEXA scan.⁵ The reference standard was the bone density of a healthy 35-year-old woman. By this definition, any woman whose bones had decreased from their youthful peak — which describes virtually every woman over 50 — could be diagnosed with osteopenia or osteoporosis. The condition “osteopenia” did not exist as a clinical category before this redefinition.⁸ Internal Merck memos described the company’s excitement about the new diagnostic category and the market it would create for Fosamax.⁸

The DEXA scan measures bone mineral density. That is all it measures. It cannot assess the collagen matrix — the protein scaffolding on which the minerals deposit. A baby has very low bone mineral density and rarely fractures. An elderly woman with osteoporosis may have adequate minerals deposited in the wrong locations, including her arteries. Bone strength is a property of the matrix as much as of the minerals; the DEXA captures only one of the two and is treated as if it captured both.³

Bisphosphonate drugs raise the number the DEXA measures. They do not so much prevent fractures as change the kind of fracture. Documented harms include osteonecrosis of the jaw — the jawbone literally dying — and atypical femur fractures, where the thigh bone snaps under minimal stress in patients taking drugs prescribed to prevent fractures.⁹,¹⁰ The absolute fracture reduction in randomised trials is 1–2%. Fifty to a hundred women must be treated for years to prevent a single hip fracture, while every one of them carries the risks above.⁸

What to Ask Before Your Next Bone Density Scan – Unbekoming

2. Cholesterol

The cholesterol threshold for statin prescription has been lowered repeatedly since 1988, by panels whose members held financial relationships with the manufacturers of the drugs being recommended.⁴ The 2004 National Cholesterol Education Program guidelines tripled the number of Americans classified as needing treatment. The Washington Post reported the panel’s undisclosed conflicts. The guidelines remained unchanged.⁴

The cholesterol hypothesis has the unusual property of being unfalsifiable. The MRFIT trial followed 361,662 men and found that those with cholesterol below 170 had double the death rate from cerebral haemorrhage of those with higher levels; below 160 the death rate quadrupled.¹¹ The Sydney Diet Heart Study, recovered and reanalysed by Christopher Ramsden, found that men who replaced saturated fats with vegetable oils had a 62% higher death rate.¹² The Minnesota Coronary Survey, hidden for decades, showed that for every 30 points cholesterol decreased, mortality increased by 22%.¹¹ None of this has altered the trajectory of the threshold or the prescription.

The statin absolute risk reduction in primary prevention — people without existing heart disease — is approximately 1–2% over five years.¹³ Advocates present this as a 30–40% reduction by using relative risk. The numbers describe the same trial result. The first is what the patient experiences; the second is what the press release says. Patients are not shown the first.

Statins raise blood glucose. The Crestor label states that statin-induced glucose elevations “may exceed the threshold for the diagnosis of diabetes mellitus.” The warning was added decades after approval, after the diabetes signal had become too large to ignore.¹¹ The statin prescribed for the lowered cholesterol threshold thus produces the prediabetes captured by the next lowered threshold.

The Great Cholesterol Con (2007)Unbekoming

3. Blood Sugar — “Prediabetes”

In 2003, the American Diabetes Association lowered the threshold for impaired fasting glucose from 110 mg/dL to 100 mg/dL.⁶ The category “prediabetes,” as it functions clinically today, did not exist before this revision. Millions of additional Americans were added to the surveillance rolls. None of their blood sugar changed. A committee’s definition of normal changed.

Prediabetes is not diabetes. Many people classified as prediabetic will never develop diabetes. The label nevertheless creates patients — patients who are monitored, tested, counselled, and increasingly prescribed metformin for a number on a lab report. Metformin causes gastrointestinal distress in up to 25% of patients.¹⁴ These symptoms are typically addressed with additional medication, or attributed to irritable bowel syndrome, which becomes its own diagnostic pathway.

The label persists across the life cycle. A woman diagnosed with gestational diabetes during pregnancy — using the same threshold-lowering mechanism, which catches around 18% of pregnant women on current criteria — returns six weeks postpartum for a repeat glucose tolerance test.¹⁵ The test is unchanged. Her physiology is largely unchanged. She is re-labelled “glucose intolerant” or “prediabetic” and enters lifelong annual surveillance. The temporary pregnancy label becomes a permanent metabolic identity.¹⁵

The fasting insulin test, which would actually reveal metabolic dysfunction, is rarely ordered.¹¹ The fasting glucose, which lags behind insulin dysregulation by years, is the screening test of record. The earlier marker is upstream and dietary; the later marker is downstream and pharmaceutical. The system selects for the marker that supports its intervention.

The Mother Who Remains: How Medicine Captures Women After Birth (Part 8)Unbekoming


Group B — Overdiagnosis

Finding what would never have harmed you.

The next three screenings do not invent the condition by adjusting a threshold. They find conditions that exist by the pathology textbook’s definition but would never have caused symptoms or death. Overdiagnosis is the bulk of what these programmes produce, not a marginal side-effect of them.

4. Mammography

The 25-year Canadian National Breast Screening Study, published in the BMJ in 2014, followed nearly 90,000 women. It found no significant reduction in breast cancer mortality from mammographic screening.¹⁶ The 2013 Cochrane Review of randomised trials reached the same conclusion.¹⁷ The relative risk for all-cause mortality in well-conducted trials is 1.01 (95% CI 0.99 to 1.04) — no significant difference between the screened and the unscreened.¹⁷

What screening does find, reliably, is ductal carcinoma in situ. DCIS was a rare diagnosis before the 1980s. It now accounts for a significant proportion of all screen-detected breast cancers. Studies following women whose DCIS was missed at biopsy show that 75–90% never develop invasive cancer over 10–20 years.¹⁸ The condition is treated nonetheless — with surgery, radiation, and in some cases chemotherapy. Nearly half a million women have been diagnosed and treated for DCIS since widespread mammography began.¹⁸ The cancers they were treated for would, in the great majority of cases, never have harmed them.

Up to 60% of women who undergo annual mammograms for a decade experience at least one false positive.¹⁸ Each false positive triggers additional imaging, biopsy, and the psychological burden of waiting. A single mammogram delivers radiation equivalent to approximately 100 chest X-rays, concentrated on compressed breast tissue.¹⁸ Over a decade of annual screening that is 1,000 chest X-rays’ worth of ionising radiation aimed at the tissue the screening is supposedly protecting. A 2012 BMJ study found that women with BRCA variants who underwent mammograms before age 30 had an increased risk of developing breast cancer compared to those who did not.¹⁹

What to Ask Before Your Next MammogramUnbekoming

5. Colonoscopy

The NordICC trial, with which this essay opened, was published in the New England Journal of Medicine in 2022. It followed over 84,000 people for ten years and found an 18% reduction in cancer incidence and no significant reduction in cancer deaths.¹ Until 2022, gastroenterology had no randomised trial supporting the procedure it had been recommending for decades.

The paradox is structural. Polyps are found in 32–50% of older adults. About 5% of people develop colorectal cancer.³ The vast majority of polyps removed during colonoscopy were never destined to cause harm. The procedure removes them anyway, and each removal leaves a wound in the protective mucosal layer. A 2019 study in Gastroenterology proposed an additional mechanism — iatrogenic tumour seeding via the scope itself, where cancerous cells stick to the biopsy forceps or are aspirated into the scope’s channel and redeposited elsewhere in the colon as the scope is withdrawn.³

The bowel preparation devastates the microbial ecology of the colon. Polyethylene glycol prep causes an “instant and substantial change” in gut microbial balance.³ Beneficial populations decrease significantly. The microbiome rebounds over weeks or months but may never return precisely to its original composition. Repeated colonoscopies across decades may leave the colon both microbiologically disturbed and physically scarred — creating, plausibly, the conditions in which polyps continue to form.

Complication rates from a Canadian population study of 97,204 outpatient colonoscopies: significant bleeding in 1 in 600; perforation in 1 in 1,200; death from the procedure in 1 in 14,000.³ These are surgical-intervention rates, not the rates of a benign screening test. The procedure generates approximately $4 billion annually in the United States.³

The Colonoscopy Cartel: How Routine Screening Became a Business Model Unbekoming

6. CT Scan — The Screening Test That Causes the Disease It Looks For

A 2025 study in JAMA Internal Medicine projected that the 93 million CT scans performed in the United States in 2023 will ultimately cause approximately 103,000 future cancers — roughly 5% of all new cancer diagnoses each year.²⁰ CT usage has grown from 3 million scans in 1980 to over 90 million today, a thirty-fold increase. Medical imaging is now the primary source of radiation exposure for most Americans beyond natural background.

The radiation epidemiology is no longer in dispute. The Taiwanese registry study found that CT exposure was associated with a 2.55-fold increase in thyroid cancer risk and a 1.55-fold increase in leukaemia risk, with clear dose-response relationships.²¹ The British NHS registry study of 178,604 children found that those exposed to cumulative doses of 30 mGy demonstrated a threefold increased risk of leukaemia; exposure to 50 mGy showed similarly elevated brain tumour risk.²² Five to ten head CT scans in children under fifteen can accumulate sufficient radiation to significantly increase lifetime cancer risk.²²

Approximately 25% of CT scans reveal incidental findings — unexpected abnormalities unrelated to the original reason for imaging.²¹ The Emory University radiologist who underwent virtual colonoscopy after a routine annual physical illustrates the cascade in its full form. The scan found no colon problem but identified a kidney mass, a 2-cm liver mass, and multiple lung nodules. Further scans showed the kidney mass was a cyst. High-resolution lung scans revealed seven to eight nodules. CT-guided liver biopsy was inconclusive. PET scan was negative. Surgeons performed video-aided thoracoscopy, collapsing part of his lung to remove three small lung sections. He awoke after five hours of surgery with a chest tube, bladder catheter, central venous line, arterial catheter, spinal catheter, oxygen, heparin, prophylactic antibiotics, and patient-controlled narcotics. Five weeks before he returned to near-normal function, except for permanent rib pain from surgically interrupted nerves. The diagnosis: histoplasmosis — a common, usually asymptomatic fungal exposure.²,²³

38% of CT scans in some clinical settings are ordered for legal protection rather than clinical necessity. Only 2.2% of defensively ordered scans change patient management. Physicians who own imaging facilities order twice as many CT scans as those without financial stakes.²¹

CT Scans: The Cancer MachineUnbekoming


Group C — The Cascade

The positive result that escalates into iatrogenic harm.

The next three screenings illustrate what happens after a positive result. Each programme has its own version of the cascade, but the structure is consistent: the abnormal finding triggers a sequence of procedures whose cumulative harm to the well far exceeds any benefit to the few who genuinely had the disease being screened for.

7. PSA Testing

Richard Ablin, who first identified a prostate-specific antigen in 1970, called the use of PSA for population screening a “profit-driven public health disaster” in a New York Times op-ed in 2010.²⁴ He wrote against the screening test most associated with his name for the rest of his career. The screening continued.

PSA is prostate-specific, not cancer-specific. The protein is produced by all prostate tissue — cancerous, enlarged, inflamed, and normal. An elevated PSA can mean prostate cancer. It can also mean benign prostatic hyperplasia, prostatitis, recent ejaculation, a urinary tract infection, or simply a larger prostate. No PSA threshold reliably separates cancer from non-cancer, and no threshold separates cancers that will kill from cancers that will not.²⁵

The threshold of 4.0 ng/mL was, by the account of New York Times reporting, chosen “just sort of arbitrarily.” William Catalona’s 1991 New England Journal of Medicine paper established it without reporting false positive rates — a basic requirement for any screening test.²⁵,²⁶ The world adopted the number.

75% of men with elevated PSA do not have cancer. Between 30 and 100 men are overdiagnosed and overtreated for every life saved.²⁵ The 2012 Prostate Cancer Intervention Versus Observation Trial (PIVOT) and the Scandinavian Prostate Cancer Group Study found no significant survival benefit from radical prostatectomy compared to watchful waiting.²⁵ The surgery causes permanent urinary incontinence in 20–30% of men and erectile dysfunction in 60–80%.²⁵ Active surveillance is appropriate for roughly 99% of low-risk cases.²⁵

30 million American men are screened each year. The screening triggers approximately one million biopsies. At least 750,000 of those biopsies find no cancer. The programme generates $3 billion annually.²⁵ When the US Preventive Services Task Force recommended against routine screening in 2012, urology associations mobilised lobbying efforts to preserve the status quo.

The PSA Trap (2026)Unbekoming

8. Prostate Biopsy

The PSA cascade leads to the biopsy. Standard transrectal biopsy routes 10–18 needles through the rectal wall into a sterile organ. The needle carries with it the bacteria living in the rectum. Published infection rates after transrectal biopsy reach 5.4%. Sepsis rates range from 0.2% to 9.4% depending on the setting. Between 50,000 and 150,000 men are hospitalised worldwide each year for post-biopsy infection.²⁷

The standard antibiotic prophylaxis is a fluoroquinolone. Approximately 22% of men undergoing this biopsy carry fluoroquinolone-resistant E. coli in their gut flora; the prophylactic antibiotic does not work for one in five men.²⁸ The 2022 GRAM Report in the Lancet estimated that nearly 5 million deaths worldwide in 2019 were closely associated with antimicrobial resistance, with E. coli identified as the most significant contributing organism.²⁹ Transrectal prostate biopsies continue to be performed in this resistance landscape.

A different route exists. Transperineal biopsy enters the prostate through the perineal skin, bypassing the rectum entirely. The 2024 meta-analysis published in Prostate Cancer and Prostatic Diseases found that the transperineal approach reduces infectious complications by 77%.³⁰ The transperineal route has been available for decades. The transrectal route, with its known infection profile, remains the default in most clinics.

The broader complication profile is less dramatic but affects more men. Hematuria. Hematospermia. Rectal bleeding, with severe haemorrhage in up to 1% of cases. Lower urinary tract symptoms in up to 25% post-procedure.²⁷ Tuncel and colleagues found that 41% of men reported erectile dysfunction one month after biopsy, with 15% still affected at six months.³¹ A prostate cancer diagnosis itself, even when made for an indolent cancer that would never have caused symptoms, increases cardiovascular events (relative risk 1.3) and suicide risk (relative risk 2.6) within the first year of diagnosis.³² These outcomes do not appear on the consent form. A 1999 study in Effective Clinical Practice found that 31% of men who received a PSA test were unaware their physician had ordered it; of those who were aware, only 47% recalled any discussion of risks and benefits.³³

Through the Wall: The Prostate Biopsy and What No One MentionsUnbekoming

9. Pap Smear and HPV Testing

Angela Raffle’s 2003 study in the British Medical Journal calculated the arithmetic of cervical screening. One thousand women must be screened for 35 years to prevent one death from cervical cancer. Of those 1,000 women, 150 will receive a stress-causing test result during those 35 years. About 50 will undergo cancer treatment they did not need. Fifty women treated unnecessarily for every death prevented.³⁴

The cascade from abnormal Pap to LEEP runs like this. A woman with no symptoms is screened. The cytology shows abnormal cells. She receives a letter or a call. The words used vary; the message is consistent: something is wrong, further investigation is needed. The waiting period is filled with anxiety, internet searches, and the imagining of worst cases. She undergoes colposcopy. Tissue is removed for biopsy. The cervix has nerve endings; the biopsy is painful, with bleeding and cramping. If the pathology shows precancerous changes, treatment is recommended — typically LEEP (loop electrosurgical excision procedure) or cone biopsy. A portion of the cervix is cut away.²

The harm extends to future pregnancies. LEEP and cone biopsy shorten and weaken the cervix. The woman who underwent the procedure is at increased risk of preterm birth in subsequent pregnancies. Her premature infant may require neonatal intensive care, which initiates its own cascade. A screening test administered to an asymptomatic woman has produced not only her own anxiety, procedures, and tissue loss, but increased risk to a future child.²

The new HPV DNA testing — adopted as first-line screening in Australia in 2017 and increasingly in the United States — finds the marker that most sexually active women carry. The Pap looked for abnormal cells. The HPV DNA test looks for sequences attributed to HPV. The yield of positives expands accordingly. Over 99% of those who test positive for HPV markers never develop cervical cancer.² Switching from cytology to PCR-based HPV testing broadens the pool of positives feeding the treatment cascade rather than improving the discrimination of the test.

The HPV Lie: Pap Smears, Gardasil, and a Cancer Caused by Something ElseUnbekoming


Beyond the Threshold: When the Marker Is the Construct

The first nine entries indict screening on the establishment’s own data — the studies, the trials, the autopsy reservoirs, the conflicts of interest disclosed in the papers themselves. The next three entries ask something deeper: whether the marker the test detects has any necessary connection to the disease the test claims to predict, or whether the marker itself is an artefact of a methodology that produces what it looks for.


Group D — Tests That Measure Nothing Real

The marker is a construct.

10. PCR

Kary Mullis won the 1993 Nobel Prize in Chemistry for inventing the polymerase chain reaction. He spent much of the remainder of his career warning that PCR should not be used for diagnostic purposes. “PCR is just a process that allows you to make a whole lot of something out of something,” Mullis said in 1997. “It doesn’t tell you that you are sick, or that the thing that you ended up with was going to hurt you or anything like that.” In another formulation: “With PCR, if you do it well, you can find almost anything in anybody.”³⁵

PCR doubles the targeted nucleotide sequence with each cycle. After 20 cycles, a millionfold amplification. After 30 cycles, a billionfold. At 40 cycles, a trillionfold.³⁵ The MIQE guidelines — the internationally recognised standard for PCR methodology — state that “Cq values higher than 40 are suspect because of the implied low efficiency and generally should not be reported.”³⁶ Harvard epidemiologist Michael Mina, quoted in the New York Times in August 2020, said he would set the threshold at 30 or even less.³⁷ The Corman-Drosten protocol, which became the basis for COVID-19 PCR testing worldwide, used 45.³⁸

The 2006 Dartmouth-Hitchcock incident demonstrated the mechanism in miniature. Hospital staff developed a persistent cough. A rapid molecular test was deployed. 142 staff tested positive for pertussis. Nearly 1,000 were taken off work. Thousands received antibiotics. 3,599 doses of pertussis vaccine were administered. By year’s end, the established gold-standard culture results returned. Not a single case of pertussis was confirmed. The outbreak had been manufactured by the test.³⁵

In May 2020, Tanzania’s President John Magufuli submitted samples from a papaya, a quail, and a goat to the national laboratory under false names. The papaya and the goat tested positive for COVID-19.³⁵ The 27 different PCR test manufacturers examined in Dutch court proceedings all carried the same product disclaimer: “Research Use Only (RUO), not for diagnostic purposes.”³⁵

The WHO’s August 2020 case definition completed the circle: “a person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms.”³⁵ A person with no symptoms was a confirmed case of disease on the basis of a biochemical reaction in a laboratory.

Interview with Jamie AndrewsUnbekoming

11. Antibody Tests

The antibody test inverts traditional immunology. The presence of antibodies was historically interpreted as evidence of recovery and protection: the body had encountered something, responded to it, and was now resistant. HIV testing reinterpreted a positive antibody result — for the first time in the history of immunology — as evidence of an active, ongoing, deadly infection rather than a successful response.³⁵

The reliability of the reinterpretation depends on whether the test detects antibodies specific to the claimed agent. The HIV antibody test manufacturer’s insert states: “There is no recognized standard for establishing the presence or absence of antibodies to HIV-1 and HIV-2 in human blood.”³⁵ The German weekly Die Woche ran a headline calling this “The AIDS Test Lottery,” reporting that “the antibody tests do not measure what they should: HIV infection. They also react to people who have overcome a tuberculosis infection.”³⁵

Nancy Banks compiled a list of more than sixty conditions known to cause false-positive HIV antibody results — kidney failure, tuberculosis, flu, flu vaccination, tetanus vaccination, malaria, haemophilia, leprosy, and pregnancy in women who have given birth multiple times.³⁹ The proteins in the test, Banks writes, “are cellular in origin and are not specific to HIV.” The calibration was circular: proteins that caused the strongest reaction in seriously ill AIDS patients were selected to define the test. That those proteins had any connection to a retrovirus of any type was never independently established.³⁵

The monoclonal antibodies that became the diagnostic industry’s stock in trade were developed in 1975 through hybridoma technology — fusion of cancerous myeloma cells with mouse spleen cells. These are laboratory-manufactured chimeras that exist nowhere in nature. Harvard’s Clifford Saper has confirmed that they bind indiscriminately to similar protein sequences rather than to a single specific target.⁴⁰ Children born with agammaglobulinaemia, who produce none of what immunology calls antibodies, recover from illness normally.⁴⁰ The British Medical Research Council’s 1950 Report #272 found no correlation between antibody count and susceptibility to diphtheria.⁴⁰

The antibody test is the mechanism by which a healthy person becomes a sick one on paper. It measures cross-reactive binding to uncharacterised proteins and reports the binding as specific recognition of a pathogen.

The Antibody Deception: Invisible Enemies, Visible LiesUnbekoming

12. BRCA Testing and Prophylactic Mastectomy

In 1994, Yoshio Miki and colleagues published in Science the identification of a gene they named BRCA1, associated with breast cancer in selected families.⁴¹ The 80–87% lifetime risk figure that drives prophylactic mastectomy decisions today derives from families chosen for inclusion because they had extreme cancer clustering — six, eight, ten cases across generations. This is ascertainment bias. A 2007 simulation analysis in the Journal of Medical Genetics quantified its magnitude: risk estimates from clinically ascertained families are inflated by a factor of two to three.⁴² A 2019 study in the European Journal of Human Genetics found the bias to be pervasive and unacknowledged.⁴³ The corrected estimates were rarely communicated to women making surgical decisions.

35–55% of BRCA variant carriers never develop breast cancer. The papers themselves document women carrying clearly “deleterious” mutations who lived to age 80 without malignancy.⁴¹ Compare this with Huntington’s disease, the case mainstream genetics treats as definitive — penetrance reportedly approaching 100% in carriers of the expanded repeat. A sequence variant that fails to produce the disease in half its carriers cannot be the cause of the disease; at most, it is a correlate in pre-selected families.

The 2002 BMJ study by Metcalfe and colleagues examined women who had already undergone prophylactic bilateral mastectomy after BRCA testing. Most overestimated their cancer risk by more than 90% compared with computer-generated estimates.⁴⁴ Twenty-two of seventy-five women believed their risk was 100%. The eighteen women with the lowest computed risk — those with limited family history — believed their risk was highest, averaging 80% when the models gave 12%. Their belief was wrong by a factor of seven. The machinery that produced the belief — the testing, the counselling, the risk communication — failed them. They removed healthy breasts.

The original BRCA papers carry conflict-of-interest disclosures. The race to identify the genes was explicitly a race to patent them. Myriad Genetics won and held a monopoly on the test until the 2013 Supreme Court ruling in Association for Molecular Pathology v. Myriad Genetics.⁴⁵ At peak, BRCA testing alone generated over $500 million annually. Preventive surgeries, surveillance, and PARP inhibitors added billions.

Healthy women with no symptoms are routed toward mastectomy and oophorectomy on the basis of a probability inflated by ascertainment bias, applied to laboratory markers whose causal connection to the cancer has never been established outside the families originally selected for clustering. They are not given the corrected numbers. They are not told that 35–55% of carriers never develop the disease. They are told they have a gene that causes cancer, and they are routed to the operating theatre.

The BRCA Gene and the Women Who Lost Their Breasts to a HypothesisUnbekoming


What the Twelve Have in Common

Twelve tests. Four mechanisms. One output: more patients.

The threshold-manipulation group converts the well into the sick by lowering the cutoff. The drug to treat the new diagnosis is manufactured by the company whose representative sat on the panel that lowered the cutoff. The body is unchanged.

The overdiagnosis group finds conditions that exist by the textbook definition but would never have caused symptoms or death. The mammogram finds DCIS that would have resolved or remained dormant. The colonoscopy finds polyps that were never destined to become cancer. The CT scan finds incidentalomas that lead to thoracic surgery for histoplasmosis.

The cascade group illustrates what a positive result produces. The PSA leads to the biopsy that leads to the sepsis that leads to the radical prostatectomy that leads to the incontinence and impotence — for cancers that, in autopsy series, are present in 70% of men over 80 and kill 3%. The Pap smear leads to the colposcopy that leads to the LEEP that leads to the preterm birth in a future pregnancy. The biopsy needle is the test as injury.

The marker-as-construct group asks the deeper question of whether the test detects what it claims to detect. PCR amplifies fragments and is read as detection of a whole organism it never isolates. The antibody test picks up cross-reactive binding and reports it as specific recognition. The BRCA test identifies a correlate in pre-selected families and frames it as a deterministic cause.

Each of these tests was developed for a specific clinical purpose: PSA to monitor men already diagnosed with prostate cancer, mammography to investigate palpable breast lumps, colonoscopy to assess symptomatic patients. They worked reasonably well within that scope. Repurposed to screen the asymptomatic, on the intuition that earlier detection must help, they fail because most of what they find is pseudodisease and the cascades they trigger produce harm exceeding any benefit to the few with genuine disease.²

The reservoir is vast. Seventy percent of men in their seventies harbour prostate cancer at autopsy. Up to 39% of middle-aged women show evidence of breast cancer at autopsy. Polyps are present in half of older colons. Thyroid cancer appears in nearly every carefully examined thyroid.² Every screening test dips into this reservoir. Every person pulled from it becomes a patient who cannot benefit from treatment, because they were never at risk.

The financial architecture is consistent across the catalogue. Colonoscopy generates $4 billion annually in the United States.³ PSA produces $3 billion.²⁵ CT scanning is a multi-billion-dollar industry.²¹ The DCIS treatment cascade — surgery, radiation, follow-up — runs to tens of thousands of dollars per case across hundreds of thousands of cases.¹⁸ BRCA testing exceeded $500 million annually at peak; the downstream surgeries and PARP inhibitors add billions. Each abnormal result triggers a sequence of follow-up procedures that generates more revenue. No conspiracy is required — only that every participant follow their own incentives.

The system is sustained, in large part, by the people it overdiagnosed. Every person overtreated for pseudodisease becomes, in their own telling, a survivor. They believe the screening saved their life, and they say so — to their families, to their neighbours, at fundraisers, and before parliaments. The screening programmes’ most effective advocates are the women whose healthy breasts were removed for a non-progressing DCIS, the men whose prostates were taken out for indolent cancers that would never have killed them, the people who were treated for a disease they never had and now organise their identity around the rescue. They are not lying. The framework that taught them to be grateful cannot acknowledge their mistake without dismantling itself.


How to Explain This to a Six-Year-Old

Some grown-ups have machines that look inside your body to find things that might be dangerous. They say finding things early is good, and going to the doctor sounds safe.

Here is what they don’t tell you. The machines find lots of small things that were never going to hurt you. Sometimes they find nothing at all and say they found something. Sometimes they find a piece of something and pretend it is the whole bad thing.

Once the machine says it found something, the grown-ups cut it out, or give you medicine to fight it, or make you come back every year to check. The cutting and the medicine often hurt you more than the thing would have.

The grown-ups also have a rule about what counts as sick. They get to change the rule. Every few years they change it so that more people are called sick. The people who change the rule are often paid by the companies that sell the medicine for being sick.

You can feel fine on Monday and be called sick on Tuesday, and nothing inside you changed. Only the rule changed.


Closing

The body that was well on Monday is a patient on Tuesday. Nothing inside it changed. The number on the chart changed.

A committee lowered a cutoff. A scan found a shadow. A biopsy went through the wall and brought back what it always brings back. A PCR amplified a fragment 35 trillion times and the result was labelled detection of a virus. A sequence variant labelled BRCA1, present in hundreds of thousands of women, was assigned a probability inflated by ascertainment bias and then offered as the basis for removing healthy breasts.

The twelve tests are not twelve separate stories. They are one story in twelve forms — the conversion of the well into the patient. The conversion is achieved through thresholds set by people who profit when the threshold moves; through overdiagnosis of conditions that would never have mattered; through cascades that begin with a positive result and end in the operating theatre or the morgue; and through markers whose existence, as the test claims them, is itself unverified.

The screened do not live longer than the unscreened. The trials are explicit on this point. The benefit the programmes advertise is disease-specific mortality; the number they bury is all-cause mortality. Moving the first without moving the second relocates death rather than preventing it.

The information needed to see this is not behind a paywall. It sits in the journals the physicians ordering these procedures subscribe to and cite — the NEJM, the BMJ, JAMA, the Cochrane reviews. It appears in the disclosures attached to the original papers, the financial filings of the companies that hold the patents, the consent forms no one reads aloud, the package inserts no one is handed, and the policy documents no one quotes back at the practice.

The document exists. The data exists. Most patients who go through these procedures never see them.


References

  1. Bretthauer M, Løberg M, Wieszczy P, et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. New England Journal of Medicine. 2022;387(17):1547–1556.
  2. Welch HG. Should I Be Tested for Cancer? Maybe Not and Here’s Why. University of California Press, 2004. Welch HG, Schwartz L, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. Beacon Press, 2011.
  3. Source materials on colonoscopy screening, including: Bretthauer et al. (2022), as in reference 1; Gastroenterology (2019) on iatrogenic tumour seeding via colonoscope; Canadian population study of 97,204 outpatient colonoscopies on complication rates; Yoho R. Butchered by Healthcare, on procedure economics.
  4. Lenzer J. Majority of panelists on cholesterol guidelines have current or recent ties to drug industry. BMJ. 2004;328(7452):8. See also Abramson J, Wright JM. Are lipid-lowering guidelines evidence-based? The Lancet. 2007;369(9557):168–169.
  5. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. Journal of Bone and Mineral Research. 1994;9(8):1137–1141. WHO Study Group on Assessment of Fracture Risk. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843, 1994.
  6. Genuth S, Alberti KG, Bennett P, et al. Follow-up Report on the Diagnosis of Diabetes Mellitus. Diabetes Care. 2003;26(11):3160–3167.
  7. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology. 2018;71(19):e127–e248.
  8. Source materials on bisphosphonates and bone density, drawing on Cowan T, clinical writing and webinars; Dean C. Death by Modern Medicine; and internal Merck communications regarding Fosamax marketing as discussed in The Architecture of Deception.
  9. Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research. 2014;29(1):1–23.
  10. Khan AA, Morrison A, Hanley DA, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of Bone and Mineral Research. 2015;30(1):3–23.
  11. Kendrick M. The Great Cholesterol Con: The Truth About What Really Causes Heart Disease. John Blake Publishing, 2008. Kendrick M. The Clot Thickens: The Enduring Mystery of Heart Disease. Columbus Publishing, 2021. Ravnskov U. The Cholesterol Myths. NewTrends Publishing, 2000. MRFIT data and Crestor labelling as discussed in these works.
  12. Ramsden CE, Zamora D, Majchrzak-Hong S, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968–73). BMJ. 2016;353:i1246. Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707.
  13. Abramson JD, Rosenberg HG, Jewell N, Wright JM. Should people at low risk of cardiovascular disease take a statin? BMJ. 2013;347:f6123.
  14. McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia. 2016;59(3):426–435.
  15. Source materials on gestational diabetes thresholds and postpartum glucose surveillance from Medicalized Motherhood, including current ACOG and ADA screening protocols.
  16. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty-five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366.
  17. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews. 2013;6:CD001877.
  18. Source materials from Breast Cancer: What They Didn’t Tell You and The Screening Trap, drawing on Welch HG and colleagues on DCIS overdiagnosis; BMJ 25-year follow-up (Miller et al. 2014); and false-positive rate analyses from US and UK screening programs.
  19. Berrington de González A, Reeves G. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits. British Journal of Cancer. 2005;93(5):590–596. See also: Pijpe A, Andrieu N, Easton DF, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ. 2012;345:e5660.
  20. Smith-Bindman R, Chu PW, Azman Firdaus H, et al. Projected lifetime cancer risks from current computed tomography imaging. JAMA Internal Medicine. 2025.
  21. Source materials from The Screening Trap, including Taiwanese registry analyses of CT-associated cancer risk; defensive medicine ordering rates; self-referral ordering studies; and Cedars-Sinai radiation overexposure incident (2008–2009).
  22. Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. The Lancet. 2012;380(9840):499–505.
  23. Welch HG. Should I Be Tested for Cancer? Maybe Not and Here’s Why, on the Emory University radiologist case of incidentaloma cascade following virtual colonoscopy.
  24. Ablin RJ. The Great Prostate Mistake. The New York Times. March 9, 2010.
  25. Source materials from The PSA Trap and The Screening Trap, drawing on Catalona WJ et al. (1991), New England Journal of Medicine, original PSA threshold paper; Wilt TJ et al. PIVOT trial, NEJM 2012; Bill-Axelson A et al. Scandinavian Prostate Cancer Group Study; and US Preventive Services Task Force recommendation statements.
  26. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New England Journal of Medicine. 1991;324(17):1156–1161.
  27. Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. European Urology. 2013;64(6):876–892.
  28. Taylor AK, Zembower TR, Nadler RB, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. Journal of Urology. 2012;187(4):1275–1279. See also: Taylor S, Margolick J, Abughosh Z, et al. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. Journal of Urology. 2011 (PMID:21958149) — the source for the ~22% fluoroquinolone-resistance prevalence in gut flora prior to transrectal biopsy.
  29. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–655.
  30. Wolff EM, Tafuri A, Mazzone E, et al. Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis — a systematic review including meta-analysis. Prostate Cancer and Prostatic Diseases. 2024. See also: Hu JC, Tosoian JJ, Qi J, et al. Transperineal vs transrectal prostate biopsy — the PREVENT randomized clinical trial. JAMA Oncology. 2024;10(10):1590–1593.
  31. Tuncel A, Toprak U, Balci M, et al. Impact of transrectal ultrasound-guided prostate biopsy on erectile function in patients with lower urinary tract symptoms. Journal of Andrology. 2008;29(3):344–348.
  32. Fang F, Keating NL, Mucci LA, et al. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. Journal of the National Cancer Institute. 2010;102(5):307–314.
  33. Federman DG, Goyal S, Kamina A, Peduzzi PN, Concato J. Informed consent for PSA screening: does it happen? Effective Clinical Practice. 1999;2(4):152–157.
  34. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ. 2003;326(7395):901.
  35. Bailey M, Bailey S. The Final Pandemic: An Antidote to Medical Tyranny. 2022. Engelbrecht T, Köhnlein C, Bailey S, Bailey M, Scoglio S. Virus Mania. 3rd English Edition, 2021. Mullis K. “Corporate Greed & AIDS” talk, Santa Monica, California, 1997. Multiple Mullis quotations on PCR limitations as documented in these sources.
  36. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry. 2009;55(4):611–622.
  37. Mandavilli A. Your coronavirus test is positive. Maybe it shouldn’t be. The New York Times. August 29, 2020. Quoting Michael Mina, Harvard T.H. Chan School of Public Health.
  38. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25(3):2000045.
  39. Banks NT. AIDS, Opium, Diamonds, and Empire: The Deadly Virus of International Greed. iUniverse, 2010.
  40. Stone M. The Antibody Deception: Invisible Y’s That Don’t Exist. Source for the Saper observation on monoclonal antibody binding; on agammaglobulinaemia recovery; and on British Medical Research Council Report #272 (1950).
  41. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66–71.
  42. Goldgar D, Venne V, Conner T, Buys S. BRCA phenocopies or ascertainment bias? Journal of Medical Genetics. 2007;44(8):e86.
  43. Ranola JMO, Tsai GJ, Shirts BH. Exploring the effect of ascertainment bias on genetic studies that use clinical pedigrees. European Journal of Human Genetics. 2019;27(12):1800–1807.
  44. Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA. An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. Journal of Medical Genetics. 2000;37(11):866–874. Metcalfe K, Narod SA, et al. Women who undergo prophylactic bilateral mastectomy overstate risk of cancer. BMJ. 2002;325(7369):921.
  45. Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013).

June 14, 2026 Posted by | Corruption, Deception, Science and Pseudo-Science, Timeless or most popular | Comments Off on The 12 Screenings That Manufacture the Patients They Claim to Find

What Is SIDS?

An Essay on the Diagnostic Category Built to Receive What Cannot Be Officially Named

Lies are Unbekoming | June 9, 2026

Sudden Infant Death Syndrome is officially defined as “the sudden death of an infant under one year of age, which remains unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of the clinical history.”¹

By its own definition, it is a non-explanation. A baby cannot be diagnosed with SIDS while alive. SIDS cannot kill a baby. The category exists to receive deaths whose cause cannot be officially acknowledged.

Before 1969, this category did not exist. Before organized vaccination programs expanded in the 1960s, what was then called crib death was so rare that it was not mentioned in infant mortality statistics.² The term Sudden Infant Death Syndrome was created in 1969 in response to a rise in unexplained infant deaths that coincided with expanded vaccination campaigns. By 1972, SIDS had become the leading cause of post-neonatal mortality in the United States, the leading cause of death between 28 days and one year of age.³ A category that had not existed three years earlier had become the dominant verdict on dead infants.

There are 130 official ways for an infant to die, as categorized in the International Classification of Diseases. There is no official way to die from a vaccine. That classification was removed in 1979.⁴ Medical examiners working since then have been given a manual that contains every imaginable cause of infant death except the one that the public record, the manufacturer’s own clinical trial data, and a half-century of clustering evidence all point to.

Before SIDS Existed

The 1967 Pediatrics review by Maria Valdes-Dapena examined the world literature on sudden unexpected infant deaths from 1954 to 1966. The review documented a rising phenomenon in industrialized nations, with the author professing herself “woefully ignorant” of the cause.⁵ The deaths were already occurring. They had not yet been categorized.

A causal connection to vaccination was made early. Within fifteen years of the Valdes-Dapena review, William Torch presented findings at the 1982 American Academy of Neurology Conference identifying DPT vaccination as a potential cause of the deaths the new category had been created to receive.⁶ The category was new. The deaths were not. What was new was the schedule that produced them and the institutional naming that made them legible only as a syndrome of unknown origin.

In 1969, when the term Sudden Infant Death Syndrome was created, the United States was four years past the introduction of the measles vaccine and five years past the licensing of the oral polio vaccine. DPT was being administered at expanded coverage. Mumps and rubella vaccines had been licensed. The childhood schedule was growing rapidly. Pre-1969, organized vaccination of infants was limited; crib death was rare and unstratified.² The temporal alignment between the expansion of the schedule and the creation of the category to absorb the resulting deaths went unnoticed because nobody was looking. There was no institutional reason to look.

In 1973, the National Center for Health Statistics, operated by the CDC, created a new cause-of-death category specifically for SIDS.² Certifiers were required to use it. By the late 1970s, the institutional infrastructure was nearly complete. What remained was the elimination of the alternative.

The 1979 revision of the International Classification of Diseases eliminated all cause-of-death classifications associated with vaccination.⁴ Previous versions of the ICD had listed “prophylactic inoculation and vaccination” as a separate cause-of-death category, with subcategories for deaths caused by specific vaccines. The 1979 revision and every subsequent update removed these. Since 1979, medical certifiers have had no code to assign vaccine-related deaths to. They are required, by the structure of the manual they use, to assign the death to a different category.

The asymmetry this produces is striking. The same federal government that maintains the ICD code structure also operates the National Vaccine Injury Compensation Program, established by the National Childhood Vaccine Injury Act of 1986. As of May 2021, the Vaccine Injury Compensation Program had awarded more than $4.5 billion in compensation for vaccine injuries and deaths.⁷ The federal government, in one capacity, compensates families for deaths caused by vaccines. The same federal government, in another capacity, removes the cause-of-death code that would allow those deaths to be officially documented in mortality statistics. The compensation requires the cause; the mortality statistics deny it. Both are operated by the same institution.

This structure has been in place for forty-six years. Every infant death that has occurred in temporal proximity to vaccination since 1979 has been recorded under a different code than the one that would name what happened. SIDS, “accidental suffocation,” “unknown cause,” “unspecified viral disease,” “diseases of the blood,” “cardiac arrest,” and “shaken baby syndrome” are among the 130 categories that have absorbed these deaths.² The codes operate as containers. The volume of what they contain has grown as the schedule has grown.

The Pattern That Should Not Exist

The strongest single piece of evidence for what SIDS contains is the temporal distribution of infant deaths relative to vaccination. Neil Miller’s 2021 analysis of the Vaccine Adverse Event Reporting System database, published in Toxicology Reports, examined 2,605 infant deaths reported between 1990 and 2019.⁸ The findings were specific and statistically definitive.

Of all reported infant deaths, 58% occurred within three days of vaccination, and 78.3% occurred within seven days. For the subset of deaths labeled SIDS specifically, 51% occurred within three days and 75.5% within seven days. The highest single-day count was day two after vaccination, with 760 reported infant deaths. The expected count for any single day if the deaths were randomly distributed across the sixty-day post-vaccination window analyzed would be approximately 43. Day two showed a 69-fold elevation over chance.⁸

The statistical significance was p < 0.00001. The probability that the observed clustering occurred by chance is less than one in 100,000.

In concrete terms: each day represents 0.27% of the year, and a seven-day window represents 1.9% of the year. If infant deaths bore no temporal relationship to vaccination, the proportion of deaths falling within seven days of a vaccination event would approximate the proportion of days the window represents. The observed figure is 78.3%. That is forty-one times the baseline expectation. The biological mechanism describes how the deaths occur. The temporal density demonstrates that they occur because of the intervention they cluster around.

The pattern was identified before Miller’s analysis. In 1982, William Torch presented data on seventy SIDS cases reported in Nevada. 6.5% of infants died within twelve hours of DPT vaccination, 13% within twenty-four hours, 26% within three days, and 37%, 61%, and 70% within one, two, and three weeks respectively.⁶ The clustering was visible in 1982. It has been visible for forty-three years.

In 1987, Alexander Walker of the Boston University Medical Center and the Harvard School of Public Health published findings in the American Journal of Public Health on US children born between 1972 and 1983 who received the diphtheria-tetanus-whole cell pertussis vaccine. Infants weighing more than 2,500 grams at birth experienced 7.3 times more SIDS within three days of DTP vaccination than during a period starting thirty days after vaccination. The 95% confidence interval ranged from 1.7 to 31.⁹ The lead author was affiliated with Harvard and the finding was published in a major public health journal. The institutional reaction was silence.

The manufacturer’s own data confirms what the epidemiological data shows. A confidential GlaxoSmithKline clinical study report on the hexavalent vaccine, made publicly available by an Italian court, documented that 65 of 67 sudden infant deaths occurring during the trial (97%) occurred within the first ten days after vaccination. Just two deaths occurred in the next ten days.¹⁰ Across the manufacturer’s own data, 62.7% of sudden infant deaths occurred within three days of vaccination and 89.6% within seven days. Six of the eight sudden deaths in children during their second year of life occurred within three days of vaccination.¹⁰ The manufacturer concluded that the vaccine did not increase the risk of sudden death. European regulators accepted the conclusion.

Independent autopsy findings confirm the relationship at the level of individual cases. Zinka and colleagues, publishing in Vaccine in 2006, documented six cases of sudden infant death occurring within forty-eight hours of hexavalent vaccination. Autopsies showed unusual neuropathology in the brains of these infants. The authors calculated a 13-fold increase in the risk of sudden death after hexavalent vaccination compared with an earlier period before the multi-dose vaccine was available.¹¹ D’Errico and colleagues, in 2008, examined a three-month-old infant who died within twenty-four hours of hexavalent vaccination. They concluded that acute respiratory failure due to post-vaccination shock was the cause of death.¹² Ottaviani and colleagues, in Virchows Archiv in 2006, documented a separate case of sudden infant death shortly after hexavalent vaccination, identifying the vaccine as the likely trigger of the lethal outcome.¹³

In 1978 and 1979, eleven infants in Tennessee died within eight days of DPT vaccination. Five died within twenty-four hours. Nine of the eleven had received their vaccine from the same lot, Wyeth Lot #64201.² A subsequent investigation confirmed a greater-than-expected relationship between the lot and the deaths. The FDA initially stated that a causal relationship could not be totally excluded. Later statements walked this back to “experts did not find evidence of a cause-effect relationship.” The CDC ultimately classified the deaths as coincidence.² Internal memos from the manufacturer, surfaced afterward, revealed a new shipping policy: no geographical location would receive all of its DPT vaccine from a single lot, ensuring that any future clustering would be statistically diluted across regions. The structural ability to detect hot lots was deliberately broken.

In a 2017 case before the National Vaccine Injury Compensation Program, the Special Master awarded compensation to the parents of a four-month-old infant who died the day after receiving seven vaccines. The ruling concluded that vaccines “likely did play a critical role in this child’s death” by stimulating inflammatory cytokines that suppressed the respiratory system and prevented normal response to carbon dioxide accumulation.¹⁴ The vaccine court awarded the compensation. The death certificate listed something else.

The Brainstem and the Empty Autopsy

The clustering data demonstrates that the deaths occur. The mechanism explains how, and the convergence of two independent mechanistic accounts on the same anatomical target, the brainstem respiratory control region, also explains why the autopsy finds nothing.

The first account begins with what aluminum does in tissue. Aluminum adjuvants are present in multiple vaccines administered during the first eighteen months of life, including hepatitis B, DTaP, Hib (some formulations), pneumococcal conjugate, and hepatitis A.¹⁵ The total dose of injected aluminum received by a fully vaccinated child has approximately quadrupled since the 1980s, from around 1,000 micrograms by age eighteen months under the schedule in place before the 1986 NCVIA to over 4,000 micrograms today.¹⁵ Aluminum is biopersistent. Gherardi and colleagues, publishing in Frontiers in Neurology in 2015, documented that aluminum hydroxide particles persist at injection sites and undergo slow CCL2-dependent translocation from muscle to brain via macrophage transport.¹⁶ Christopher Exley’s work in 2018 documented elevated aluminum levels in the brain tissue of individuals diagnosed with autism, demonstrating that injected aluminum reaches and persists in the brain.¹⁷ Khan and colleagues in 2013 documented the mechanical pathway of this translocation: biopersistent particles taken up by phagocytes, transported through lymphatic and circulatory routes, deposited in distant tissues including the central nervous system.¹⁸ Yao and colleagues, in 2015, showed that hepatitis B vaccination of postnatal rats modulates hippocampal synaptic plasticity and produces a four-fold elevation in the inflammatory cytokine IL-6, demonstrating that the vaccines themselves, not just isolated aluminum, produce these effects in the developing brain.¹⁹

When an infant receives multiple aluminum-containing vaccines simultaneously, the inflammatory cascade is rapid and substantial. Microglia in the brainstem become activated. Activated microglia release glutamate and other excitotoxic compounds, along with pro-inflammatory cytokines, into the surrounding tissue.²⁰ The brainstem contains the respiratory control center. When microglial activation in this region releases excitotoxins, the infant’s breathing is suppressed. If the suppression is severe enough and sustained enough, the infant stops breathing. The neuropathologist Dr. Douglas Miller, in expert testimony cited in the Vaccine Injury Compensation Program ruling and Neil Miller’s 2021 analysis, described how vaccine-induced inflammatory cytokines act as neuromodulators in the infant medulla, producing an abnormal response to accumulating carbon dioxide and disorganizing respiratory control.⁸

This explains the first part of the autopsy’s silence. The pathologist who examines a baby that has died of inflammatory respiratory failure is looking for visible tissue damage: discrete lesions, hemorrhage, structural anomaly. The mechanism described does not produce visible damage in the timeframe required for death. Microglial activation triggers the excitotoxin release, the respiratory center fails, and the infant dies before any histological signature of the cytokine surge would form.²⁰ The pathologist sees a baby that has stopped breathing for no apparent reason. The cause is dispersed at a biochemical timescale the autopsy cannot resolve.

The second account begins from a different starting point and arrives at the same anatomical region. Andrew Moulden, a Canadian neurologist with PhD-level training in clinical-experimental neuropsychology, developed what he called the Moulden Anoxia Spectrum Syndromes framework.²¹ Moulden’s central observation was that injected substances disrupt the electrostatic stability of blood flow. Aluminum, which carries a positive trivalent charge, has approximately eighty-four times the agglomeration-inducing capacity of sodium. It is, in industrial terms, a flocculant, the same agent used in water treatment plants to cause suspended particles to clump and settle. Injected into human tissue and bloodstream, aluminum produces the same effect: red blood cells, white blood cells, and other formed elements clump together. The blood sludges.

The microcirculation in the brainstem (the network of capillaries supplying the respiratory control region) operates at a scale where red blood cells must pass through capillaries in single file. When the blood sludges, this single-file passage is obstructed. The result is microscopic ischemia: regions of tissue receiving insufficient oxygen because the blood cannot flow through the capillaries that supply them.²¹

The human body has blood pressure receptors. It does not have blood flow receptors.²¹ This anatomical fact is critical. When microcirculation fails at the capillary level but the larger arteries continue to maintain pressure, no warning signal is generated. The brainstem can be suffering ischemic damage in its watershed end-vascular territories (the most poorly supplied regions, including those controlling automatic respiration) while the body’s monitoring systems detect no problem. The damage is, in Moulden’s analysis, sub-clinical to the body itself.

This explains the second part of the autopsy’s silence. The damage Moulden described occurs at the level of the microcirculation, well below the resolution of conventional neuroimaging. There is no infarct visible on MRI. There is no hemorrhage to find. And in death, the body has no blood flow at all. The difference between sludged microcirculation in life and the post-mortem absence of circulation is not detectable by examination of the dead tissue. The lesion is invisible by structural design.

The two accounts converge on a single anatomical target, the brainstem respiratory control region, by different routes. The inflammatory pathway explains why activated microglia in this region kill the infant. The microcirculation pathway explains why ischemia in this region kills the infant. Both are caused by injected aluminum, both produce respiratory arrest, and neither leaves damage detectable at the resolution the autopsy uses to look.

When the official definition of SIDS requires that death “remain unexplained after a thorough case investigation, including performance of a complete autopsy,” the definition is describing a death that occurred via mechanisms structurally invisible to the investigation it requires. The autopsy comes up empty because the investigation tools cannot see what killed the baby. The verdict of “unexplained” is the predictable output of looking for the wrong kind of damage at a scale the instruments were never designed to resolve.

What Happens When You Remove the Cause

The convergent mechanism predicts a specific real-world outcome: if vaccinations are reduced, delayed, or interrupted, the deaths the SIDS category absorbs should decline. The historical and contemporary record contains multiple natural experiments testing this prediction. Each confirms it.

Japan, 1975. Between 1970 and 1974, Japanese authorities documented thirty-seven sudden infant deaths following pertussis vaccinations. In response, the Japanese government raised the age of DPT vaccination from three months to two years.²² The result, documented across the following decade, was dramatic.

Sudden vaccine-related deaths dropped from 1.47 per million doses to 0.15 per million doses, a 90% decline.²² The category of “sudden death” following vaccination, in the analysis of Cherry and colleagues published in Pediatrics, “disappeared following both whole-cell and acellular vaccines when immunization was delayed until a child was 24 months of age.”²² Japan’s overall infant mortality rate across all causes declined from 12.4 to 5.0 per 1,000 live births over the decade following the schedule change, a 60% improvement.²² The Task Force on Pertussis and Pertussis Immunization that produced the report concluded: “It is clear that delaying the initial vaccination until a child is 24 months, regardless of the type of vaccine, reduces most of the temporally associated severe adverse reactions.”²²

The Japanese experiment did not require a placebo group, randomization, or a controlled trial. It was a real-world intervention with a clear before-state and a clear after-state, with vaccination timing as the single variable change between them. The infant mortality decline cannot plausibly be attributed to anything else. The Japanese government delayed vaccination. Fewer babies died.

COVID lockdowns, 2020. During the early lockdown period of 2020, routine well-child visits were canceled or postponed across many jurisdictions, and childhood vaccination rates declined. An analysis comparing infant deaths in Oregon over the first six months of 2020 against the ten-year average documented a 42% drop in infant deaths during the period when lockdowns were in place and well-baby visits were canceled.²³ Similar patterns were documented elsewhere, alongside an unprecedented decline in premature births, which are themselves linked to vaccination during pregnancy.²⁴ The vaccine safety community had predicted, before the data became available, that the lockdowns would produce a once-in-a-generation natural experiment in reduced SIDS, because if vaccines are the cause, reduced vaccination should produce reduced deaths. The data confirmed the prediction.

Florida, 2021. In the year following the lockdown-driven decline in vaccination compliance, Florida’s childhood vaccination rate dropped from 93.4% to 79.3%. All-cause infant mortality under one year of age decreased by 8.93% during the same period, a reversal of the previous year’s trend.²⁵ The single largest variable that changed in Florida between 2020 and 2021 was vaccination compliance. The infant mortality figure moved in the direction the mechanism predicts.

International comparison. A 2011 study comparing infant mortality rates across the thirty-four nations with the lowest rates found a clear correlation between the number of required childhood vaccines and infant mortality.²⁶ The United States, with the largest childhood schedule among industrialized nations, also has among the highest infant mortality rates among industrialized nations.²⁷ A separate analysis comparing vaccine doses across developed nations found a strong association between dose counts and mortality rates.²⁸ Countries that vaccinate more, more often, earlier, lose more babies.

None of these experiments meets the design specifications of a randomized controlled trial. None of them needs to. Japan’s schedule change was real. The lockdowns were real. Florida’s compliance shift was real. The infant mortality figures are public record. Four independent natural experiments, three of them documented within the past five years, all moving in the direction the convergent mechanism predicts.

How the Category Has Mutated

The institutional response to the visible clustering pattern has been to mutate the category rather than investigate the relationship. The SIDS code was never the only container available. As the visibility of vaccine-induced infant death increased, the institutional pressure to disperse those deaths across multiple cause-of-death codes increased correspondingly.

In 1992, the American Academy of Pediatrics formally recommended that infants be placed supine rather than prone during sleep. The Back to Sleep campaign launched two years later, in 1994.²⁹ The campaign came eight years after the 1986 National Childhood Vaccine Injury Act, which had itself been passed in response to congressional hearings in which parents, including Donna Gary, linked DTP vaccination to infant deaths. The Back to Sleep campaign provided an alternative narrative: SIDS was caused by sleep position, not by what was injected into the infant before the sleep occurred.

The SIDS rate appeared to decline. Between 1992 and 2001, the post-neonatal SIDS rate dropped by an average annual rate of 8.6%.² This was presented as a vindication of the sleep-position hypothesis. The numbers told a different story when examined carefully. During the same period, the post-neonatal mortality rate from “suffocation in bed” (ICD-9 code E913.0) increased at an average annual rate of 11.2%.² Sudden, unexplained infant deaths that had been classified as SIDS before the campaign were now being classified as suffocation in bed. The deaths had not declined; the label on the certificate had changed.

The reclassification accelerated. From 1999 through 2015, the US SIDS rate declined 35.8% while infant deaths due to accidental suffocation increased 183.8%.² Approximately 90% of the apparent SIDS decline can be attributed to reclassification rather than reduction.² The category became more porous as institutional pressure to disperse the deaths intensified.

In 2012, the CDC introduced a new umbrella category: Sudden Unexpected Infant Death (SUID), which encompasses SIDS along with deaths attributed to suffocation and unknown causes.²⁹ The same year, the Back to Sleep campaign was rebranded as Safe to Sleep. The two institutional moves arrived together: a broader receiving category for the deaths, and a broader messaging framework for displacing their cause. Deaths that the SIDS code might have captured in isolation could now be distributed across three subcategories under the SUID umbrella, each of which can be reclassified independently as institutional preference dictates.

Safe to Sleep expanded the messaging beyond sleep position to a long list of parental responsibilities: avoidance of soft bedding, prohibitions on bed-sharing, recommendations on breastfeeding, pacifier use, smoke exposure, room temperature, swaddling. The messaging was directed disproportionately at African American communities, where SIDS rates are higher. A 2018 analysis of safe sleep public campaign messaging found that 60% of campaign messages used guilt-based framing, placing responsibility for the death on the parent’s behavior in the hours preceding it.²⁹ The campaign installed a moral framework. Parents who lost infants to sudden death were positioned within that framework as having failed it. The cause they had not been told about, the schedule they had complied with, did not appear in the framework anywhere.

In May 2025, the National Institutes of Health terminated the Safe to Sleep campaign.²⁹ The termination came after the 2020-2022 period documented a 12% rise in sudden infant deaths.²⁹ The campaign had operated in its two forms, Back to Sleep and Safe to Sleep, for over three decades without reducing SIDS deaths in any sustained way; the numbers showed reclassification rather than prevention. Its useful institutional life had ended.

The framework Safe to Sleep installed remained operational after the campaign itself was terminated. In June 2025, parents in Allentown, Pennsylvania were charged with felonies for placing their infants in unsafe sleep positions.³⁰ The Defender, reporting on similar cases, documented police charging parents with felonies after their babies died suddenly in their sleep, based on the parents’ alleged failure to follow supine sleeping guidance.³⁰ The guilt-based moral structure Safe to Sleep had installed in 2012 was now providing the legal basis for criminal prosecution in 2025. The criminalization of parents who have lost infants to deaths the system cannot explain has institutional precedent. Sally Clark, a British lawyer, was convicted in 1999 of murdering both of her infant sons, who had died unexpectedly weeks after receiving routine vaccinations. The conviction was overturned in 2003 after the statistical evidence underpinning the prosecution was discredited. She died of acute alcohol poisoning in 2007, in the aftermath.³¹ Her case is one documented historical instance. The June 2025 prosecutions are the contemporary instance of the same dynamic operating in real time.

The trajectory is consistent. Pre-1969, the deaths exist without a category to receive them. In 1969, the SIDS category is created. In 1979, the alternative cause-of-death code, vaccination, is removed from the ICD. In 1994, the Back to Sleep campaign provides a sleep-position narrative. From 1992 through 2025, deaths are reclassified into suffocation and unknown-cause codes as institutional preference shifts. In 2012, SUID broadens the receiving framework and Safe to Sleep broadens the messaging framework. In 2025, the campaign is terminated as its useful institutional life ends, and parents begin to be prosecuted under the framework the campaign installed.

At every stage, the institutional response has been to adjust the receiving infrastructure rather than investigate what is being received. The category mutates because the underlying deaths cannot stop. The schedule cannot be paused without admitting what it does, and the deaths cannot be officially named without admitting the cause. The mutation of the category is the visible trace of the institutional refusal to do either.

What SIDS Is

The official definition of SIDS describes a death that remains unexplained after thorough investigation. The definition is precise. What it describes is a death whose cause is structurally invisible to the investigation required to confirm the absence of explanation. The category exists to receive what the system cannot officially name.

The category did not exist before 1969. It was created in the same period that the childhood vaccination schedule expanded into the population of infants under one year of age. The 1979 ICD revision then eliminated the alternative cause-of-death code; the 1994 Back to Sleep campaign installed the sleep-position narrative; the 2012 SUID expansion broadened the receiving framework and the Safe to Sleep rebrand broadened the messaging framework alongside it. The 2025 campaign termination ended one phase of the construct, and the June 2025 felony prosecutions began another.

The mechanism is understood. Aluminum adjuvants reach the infant brainstem by macrophage transport and slow translocation. Microglia in the respiratory control region activate; excitotoxins release into the breathing center. The same aluminum, through electrostatic agglomeration, sludges the microcirculation supplying the same anatomical region, producing ischemia. Both pathways suppress the infant’s respiration and produce respiratory arrest. Neither leaves damage visible at the resolution the autopsy uses to look.

The infant who dies of SIDS dies of what was injected and what its body could not clear. The autopsy finds nothing because nothing visible was left to find; the death certificate names something else because the manual contains no code for what happened.

SIDS is the name the system gives to the deaths it has built itself not to see.

How to Explain It to a Six-Year-Old

Imagine grown-ups gave babies a medicine. Some of the babies got really sick after the medicine. A few of them died.

When the grown-ups looked at the babies, they couldn’t find anything wrong with them. The hurt inside was too tiny to see, like a scratch so small you’d need a special magnifying glass for ants to see it.

So the grown-ups said, “We don’t know what happened. It’s a mystery!” And they made up a special name for the mystery. The name was SIDS.

But here’s the thing. The grown-ups do know what happened. They’ve known for a long time. The medicine has something called aluminum in it. Aluminum is the same shiny stuff your sandwich wrap is made of. It’s okay on a sandwich. It’s not okay inside a baby.

The aluminum gets into the part of the brain that tells the baby to breathe. The brain stops working right. The baby stops breathing.

But the grown-ups don’t want to tell anyone, because lots of grown-ups get money from the medicine. So they keep calling it SIDS, the mystery.

When parents started to figure it out, the grown-ups changed the name. They called it “crib death.” Then “SIDS.” Then “SUID.” Now they say the babies suffocated, and sometimes the police take the mommies and daddies to jail, even though they didn’t do anything wrong.

Every time someone gets close to the truth, the grown-ups change the name.

The babies didn’t die from a mystery. They died from the medicine.

SIDS is the name grown-ups use when they don’t want to tell the truth about why a baby died.


References

  1. Standard definition of Sudden Infant Death Syndrome as adopted by the Institute of Medicine and used by the CDC, the American Academy of Pediatrics, and the National Institute of Child Health and Human Development; cited in de Becker, G. (2022). Forbidden Facts.
  2. Miller, N. Z. (2021). “Vaccines and Sudden Infant Death: An Analysis of the VAERS Database 1990–2019 and Review of the Medical Literature.” Toxicology Reports 8: 1324–1335. Historical context including the pre-1969 absence of the category and the post-1979 reclassification patterns.
  3. National Center for Health Statistics, CDC; cited in Miller (2021).
  4. International Classification of Diseases, 9th revision (1979); subsequent revisions ICD-10 and ICD-11; analysis in Miller (2021).
  5. Valdes-Dapena, M. A. (1967). “Sudden and unexpected death in infancy: a review of the world literature 1954–1966.” Pediatrics 39(1): 123–138.
  6. Torch, W. C. (1982). “Diphtheria-Pertussis-Tetanus (DPT) Immunization: A Potential Cause of Sudden Infant Death Syndrome.” Neurology 32(4). Conference abstract, American Academy of Neurology.
  7. Health Resources and Services Administration, National Vaccine Injury Compensation Program statistical data, as of May 2021.
  8. Miller, N. Z. (2021). Toxicology Reports 8: 1324–1335. Full statistical analysis including the day-by-day clustering, the 69-fold elevation on day two, and the p < 0.00001 significance.
  9. Walker, A. M., et al. (1987). “Diphtheria-Tetanus-Pertussis Immunization and Sudden Infant Death Syndrome.” American Journal of Public Health 77(8): 945–951.
  10. GlaxoSmithKline (2012). “Confidential Clinical Study Final Report: Study 113808 (ROTA-075).” Made publicly available by Italian court order.
  11. Zinka, B., Rauch, E., et al. (2006). “Unexplained cases of sudden infant death shortly after hexavalent vaccination.” Vaccine 24(31–32): 5779–5780.
  12. D’Errico, S., Neri, M., et al. (2008). “Beta-tryptase and quantitative mast-cell increase in a sudden infant death following hexavalent immunization.” Forensic Science International 179(2–3): e25–29.
  13. Ottaviani, G., Lavezze, A. M., Matturri, L. (2006). “Sudden infant death syndrome (SIDS) shortly after hexavalent vaccination: another pathology in suspected SIDS?” Virchows Archiv 448: 100–104.
  14. National Vaccine Injury Compensation Program ruling, 2017; cited in Miller (2021) and Thomas, P. (2022). Vax Facts.
  15. Thomas, P. (2022). Vax Facts. Handley, J. B. How to End the Autism Epidemic. Aluminum content data drawn from CDC Vaccine Information Statements and Mitkus, R. J., et al. (2011). “Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.” Vaccine 29(51): 9538–9543.
  16. Gherardi, R., et al. (2015). “Biopersistence and Brain Translocation of Aluminum Adjuvants of Vaccines.” Frontiers in Neurology 6: Article 4.
  17. Mold, M., Umar, D., King, A., Exley, C. (2018). “Aluminium in brain tissue in autism.” Journal of Trace Elements in Medicine and Biology 46: 76–82.
  18. Khan, Z., et al. (2013). “Slow CCL2-dependent translocation of biopersistent particles from muscle to brain.” BMC Medicine 11: 99.
  19. Yao, Z., et al. (2015). Hepatitis B vaccination of postnatal rats modulating hippocampal synaptic plasticity and IL-6 elevation; cited in Handley, J. B. How to End the Autism Epidemic.
  20. Hedley, K., et al. (2022). “Alterations in Brainstem Respiratory Centers following Peripheral Inflammation.” Journal of Neuroimmunology 369. Hoogland, I. C. M., et al. (2015). “Systemic inflammation and microglial activation: systematic review of animal experiments.” Journal of Neuroinflammation 12: 114.
  21. Moulden, A. (2009). “What You Were Never Told About Vaccines.” Interview, VacTruth.com. BrainGuardMD.com archive. Analysis of the MASS framework, zeta potential, and microcirculation pathology.
  22. Cherry, J. D., et al., Task Force on Pertussis and Pertussis Immunization. Pediatrics. Cited in Miller (2021) and Fraser, H. (2010). The Peanut Allergy Epidemic.
  23. Snee, B., comment on A Midwestern Doctor (2022); Oregon infant death analysis comparing first six months of 2020 to the ten-year average.
  24. A Midwestern Doctor. “The Century of Evidence That Vaccines Cause Sudden Infant Deaths.” MidwesternDoctor.com.
  25. Florida Department of Health vaccination compliance data 2020–2021; CDC infant mortality data; analysis cited in A Midwestern Doctor (2022).
  26. Miller, N. Z., Goldman, G. S. (2011). “Infant mortality rates regressed against number of vaccine doses routinely given: is there a biochemical or synergistic toxicity?” Human and Experimental Toxicology 30(9): 1420–1428.
  27. CDC Childhood Immunization Schedule, comparative data 1983 and present; Thomas, P. (2022). Vax Facts; OECD infant mortality comparative data.
  28. “Neonatal, Infant, and Under Age Five Vaccine Doses Routinely Given in Developed Nations and Their Association With Mortality Rates.” Cureus.
  29. Children’s Health Defense (2025). “Media Slam NIH for Axing ‘Safe to Sleep’ Campaign — But Evidence Shows the Program Never Reduced SIDS Deaths.” American Academy of Pediatrics (1992). “Positioning and SIDS.” Pediatrics 89(6): 1120–1126. Salm Ward, T. C., Balfour, G. M. (2018). “Qualitative analysis of infant safe sleep public campaign messaging.” Pediatrics 43(2): 83–91.
  30. The Defender (June 6, 2025). “Their Babies Died Suddenly in Their Sleep. Police Are Charging the Parents With Felonies for Not Placing Infants on Their Backs.” WFMZ Allentown, PA (June 6, 2025). “Parents accused of putting their infants in unsafe sleep positions charged with felonies.”
  31. Sally Clark case (R v Clark, 2003 EWCA Crim 1020). Both sons died unexpectedly in infancy weeks after receiving routine UK childhood vaccinations; the conviction was overturned in 2003 after the statistical evidence presented by Sir Roy Meadow was discredited and previously withheld pathology evidence was disclosed.

June 13, 2026 Posted by | Deception, Science and Pseudo-Science | | Comments Off on What Is SIDS?

Documents Suggest Fauci Knew COVID Was Created in Wuhan Lab, and mRNA Vaccines Wouldn’t Work

By Michael Nevradakis, Ph.D. | The Defender | June 12, 2026

In August 2021, Dr. Anthony Fauci received a U.S. intelligence report suggesting the COVID-19 virus was developed in Chinese and U.S. labs as a bat vaccine, that it subsequently leaked from China’s Wuhan Institute of Virology, and that it contained characteristics that would make it resistant to mRNA vaccines.

The report, authored by Joseph Murphy, a major with the U.S. Marine Corps, and printed on Defense Advanced Research Projects Agency (DARPA) letterhead, was part of a tranche of documents Sen. Rand Paul (R-Ky.) released Thursday as part of his ongoing congressional investigation into the origins of COVID-19.

The documents show that not only did Fauci receive the DARPA report, but that in an Aug. 25, 2021, email to National Institutes of Health (NIH) officials, he called it “important.” “Let us discuss my going down to the White House to review the report,” Fauci wrote.

The document tranche also contained evidence that Fauci cultivated ties with intelligence agencies at least as early as 2003, the same year he received a CIA report warning of the dangers of genetically manipulating coronaviruses.

Fauci later used these intelligence connections to sway the intelligence community to support the zoonotic theory of COVID-19’s origin, the documents show.

The newly released information corroborates the testimony of CIA whistleblower James Erdman before the U.S. Senate last month. Erdman testified that Fauci led a multi-agency cover-up of COVID-19’s lab origins and that his role in the cover-up “was intentional.”

“These documents reveal a breathtaking level of manipulation — official narratives carefully engineered to shape high-level government policy,” said Stephanie Weidle, executive director of federal watchdog group Feds for Freedom. “This is corruption.”

Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense (CHD), said the revelations sound “more like a plan than a mistake or a ‘leak.’” He said:

“You can’t tell me that the scientists involved didn’t know what the outcome would be. The combination of the human recombinant virus … and a gene therapy ‘vaccine’ that was used to circumvent all other therapies that could have saved lives, created a monster of a virus, as SARS-CoV-2 mutated to stay beyond the reach of the shot.”

Paul released the documents just days after he revealed that he intends to interview Fauci in Congress later this month. In a letter to Paul dated June 9, Sen. Gary C. Peters (D-Mich.) referenced Paul’s “planned transcribed interview of Dr. Anthony Fauci later this month.”

No further information about this interview is publicly available as of press time. The Daily Caller first reported about the forthcoming interview on Tuesday. Sen. Paul’s office did not respond to The Defender’s request for comment.

Fauci accepted proposal for gain-of-function research involving bat viruses

According to the DARPA document (see page 70), dated Aug. 13, 2021, SARS-CoV-2, the virus responsible for COVID-19, “is an American-created recombinant bat vaccine, or its precursor virus.”

It was created at China’s Wuhan Institute of Virology, also known as the WIV, and U.S. institutions with the help of researchers from the EcoHealth Alliance. The virus then leaked from the Wuhan lab in August 2019.

“The details of this program have been concealed since the pandemic began,” the document states, noting, though, that the details match those contained in two research proposals, the DEFUSE proposal and the PREEMPT project.

The EcoHealth Alliance’s DEFUSE proposal involved altering bat viruses by inserting a spike protein with a furin cleavage site, to cause the virus to infect human lungs. PREEMPT involved the cultivation of Egyptian fruit bats.

University of North Carolina virologist Ralph Baric, Ph.D., and Wuhan Institute of Virology researcher Shi Zhengli, Ph.D., submitted the DEFUSE proposal to DARPA in 2017. Although DARPA rejected the proposal, scientists have suggested the rejection didn’t shut down the project.

After DARPA rejected the DEFUSE proposal, the Aug. 13, 2021, report states that DARPA then “settled with NIH/NIAID” — or the National Institute of Allergy and Infectious Diseases, led at the time by Fauci. According to the report:

“DARPA rejected the proposal because the work was too close to violating the gain-of-function (GoF) moratorium, … despite what Peter Daszak says in the proposal (that the work would not … ).

“As is known, Dr. Fauci with NIAID did not reject the proposal. The work took place at the WIV and at several sites in the US, identified in detail in the proposal.”

Baric and Fauci also closely collaborated with Peter Daszak, Ph.D. — the former president of EcoHealth Alliance, who had financial ties to the Wuhan Lab and played a key role in promoting the zoonotic theory.

In 2024, HHS suspended funding for the EcoHealth Alliance for not monitoring the safety of its coronavirus experiments.

NIH virologist Vincent Munster, Ph.D., also listed as a partner in the DEFUSE proposal, has maintained ties with Daszak and EcoHealth Alliance — including a paper they co-authored in 2022 on Nipah Virus detection in bat roosts.

In April, Baric lost his NIH grants and the University of North Carolina placed him on leave.

Last week, Munster and NIH researcher Claude Kwe Yinda, Ph.D., were charged with conspiring to smuggle biological materials, including deactivated monkeypox virus samples, into the U.S. from Africa — and allegedly lied to authorities about what they were carrying.

‘The story gets complicated’

The SARS-CoV-2 virus was likely intended to be used for a bat vaccine before it leaked from the Wuhan lab, according to the DARPA report. “The purpose of the EcoHealth program, called DEFUSE in the proposal … was to inoculate bats in the Yunnan, China caves where confirmed SARS-CoVs were found,” the report states.

However, the virus “leaked and spread rapidly because it was aerosolized so it could efficiently infect bats in caves, but it was not ready to infect bats yet, which is why it does not appear to infect bats.”

The report suggests that SARS-CoV-2 had characteristics that made it easily transmissible among human populations.

“The reason the disease is so confusing is because it is less a virus than it is engineered spike proteins hitch-hiking a ride on a SARSr-CoV quasispecies swarm. The closer it is to the final live attenuated vaccine form, the more likely that it has been deattenuating since initial escape in August 2019,” the report states.

“A year after DARPA denied this proposal to create chimeric bat viruses at the Wuhan Institute of Virology, a novel bat virus with a furin cleavage site began infecting humans in Wuhan. No other closely related virus has this furin cleavage site,” RealClearInvestigations reported in April.

The documents Paul released contain emails showing that Fauci was aware of concerns about the SARS-CoV-2 furin cleavage site early during the pandemic.

In a January 2020 email thread, Fauci responded to concerns from virologist Kristian Andersen, Ph.D., and immunologist Jeremy Farrar, Ph.D., about the presence of the furin cleavage site.

In a Jan. 31, 2020, email, Fauci wrote, “I just got off the phone with Kristian Anderson and he related to me his concern about the Furine site mutation in the spike protein of the currently circulating 2019-nCoV.”

In a later email related to these concerns, Fauci wrote, “The story gets complicated.”

DARPA: Mass vaccination actually increased risks from SARS-CoV-2 virus

The virus also contained characteristics that made it difficult to treat or prevent with mRNA vaccines, the DARPA report suggested.

“The gene-encoded, or ‘mRNA,’ vaccines work poorly because they are synthetic replications of the already-synthetic SARSr-CoV-WIV spike proteins and possess no other epitopes” — or the part of an antigen that the immune system recognizes.

The report adds:

“The mRNA instructs the cells to produce synthetic copies of the SARSr-CoV-WIV synthetic spike protein directly into the bloodstream, wherein they spread and produce the same ACE2 immune storm that the recombinant vaccine does.

“Many doctors in the country have identified that the symptoms of vaccine reactions mirror the symptoms of the disease, which corroborates with the similar synthetic nature and function of the respective spike proteins.”

The DARPA report suggested that mass vaccination campaigns actually increased the risks from the SARS-CoV-2 virus, in a manner replicating that of gain-of-function research, which increases the virulence or transmissibility of viruses. It stated:

“The potential for SARSr-CoV-WIV to deattentuate requires immediate attention. Live vaccines have been found to deattentuate in the past.

“If this is the case with SARSr-CoV-WIV, then the mass vaccination campaign actually performs an accelerated gain-of-function for it. Since it is designed for bats off of a human-susceptible SARS-CoV, vaccinating humans against it actually gains its function back towards a more deattenuated human-susceptible form.”

For the same reasons, other pandemic-related interventions such as masks would be ineffective in stopping the spread of COVID-19, the report states.

“The reasons why nonpharmaceutical interventions like masks and medical countermeasures like the mRNA vaccines do not work well can be extrapolated from the details. Masks or mRNA vaccines would not work for this material,” said former pharmaceutical research and development executive Sasha Latypova. “It is a chemical aerosol poisoning agent. DARPA knows this well.”

Certain characteristics of SARS-CoV-2 made alternative treatment options, such as ivermectin, more effective in treating COVID-19, the report suggests.

“Many of the early treatment protocols ignored by the authorities work because they inhibit viral replication or modulate the immune response to the spike proteins.

“Some of these treatment protocols also inhibit the action of the engineered spike protein. For instance, Ivermectin (identified as curative in April 2020) works throughout all phases of illness because it both inhibits viral replication and modulates the immune response.

“Of note, chloroquine phosphate (Hydroxychloriquine, identified April 2020 as curative) is identified in the proposal as a SARSr-CoV inhibitor, as is interferon (identified May 2020 as curative).”

Fauci was warned about risks of gain-of-function research in 2003

The documents Paul released this week also shed light on Fauci’s intelligence ties. In 2003, Fauci received a CIA report, “The Darker Bioweapons Future,” warning that “engineered biological agents” could lead to effects potentially “worse than any disease known to man.”

While the CIA report doesn’t mention gain-of-function research by name, it cites several examples of cases where viral transmissibility or virulence were enhanced.

The documents also contain an invitation for Fauci to participate in a July 2021 National Security Council briefing related to then-President Joe Biden’s inquiry regarding COVID’s origins — for which Fauci was exempted from a COVID-19 test.

According to Erdman’s Senate testimony last month, the Biden inquiry — and Fauci’s efforts to cover up the likely laboratory origins of COVID-19 — resulted in the White House publishing an August 2021 report that was inconclusive about the virus’s origins — even though intelligence agencies by then had evidence of a lab leak.

A March 6, 2020, email from then-NIH Director Francis Collins referenced the “Proximal Origin” paper published in the journal Nature Medicine, which found that COVID-19 emerged naturally. The paper was widely used to refute the lab-leak theory. Collins suggested that he and Fauci quietly contributed to that paper.

“FYI, this is work that Tony [Fauci], Jeremy [Farrar] … and I helped with, but are appropriately not mentioned explicitly in the paper,” Collins wrote.

“What came afterwards was information warfare,” said Karl Jablonowski, Ph.D., CHD’s senior research scientist. “The world was convinced the virus had bat origins — yet it did not infect bats.”

“The censorship in the first two years was incredibly heavy,” Latypova said. “Everyone, including currently ‘awake’ outlets like Tucker Carlson, enthusiastically endorsed the narrative of natural origin, and anyone who questioned this as bogus (myself) was kicked off all social media platforms.”

Will Fauci come clean when he testifies?

Rutgers University molecular biologist Richard Ebright, Ph.D., a critic of gain-of-function research, said Fauci has a lot to potentially answer for in his congressional interview — and that Biden’s preemptive pardon of Fauci, issued last year, won’t protect Fauci if he lies before Congress. Ebright said:

“Because Fauci’s autopen pardon covers only federal crimes that Fauci committed before Jan. 21, 2025, it does not protect Fauci from prosecution for lying to Congress in a Congressional transcribed interview or public hearing in 2026. He will not even be able to repeat previous lies with impunity in a Congressional transcribed interview or public hearing in 2026.”

Ebright said Fauci has three options — responding truthfully and “confessing that he committed conspiracy to defraud, fraud, perjury, misuse of federal funds, destruction of federal records and obstruction.” Or he can provide false testimony and risk perjury charges, or feign mental incapacitation and inability to recall.

“Erdman testified before the Senate that Fauci actively worked through the intelligence community’s COVID origin task forces to advance his own agenda and steer … COVID-19 policy,” Weidle said. “These revelations should shock no one. Yet the question remains: will anything actually be done about it?”


This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.

June 12, 2026 Posted by | Deception, Timeless or most popular, War Crimes | , , | Comments Off on Documents Suggest Fauci Knew COVID Was Created in Wuhan Lab, and mRNA Vaccines Wouldn’t Work

Ex-South Korean President sentenced for trying to provoke conflict with Pyongyang

RT | June 12, 2026

A South Korean court has sentenced former President Yoon Suk Yeol to 30 years in prison, Yonhap news agency has reported. Judges reportedly found that he ordered drones to be sent into North Korea in order to inflame tensions and create a pretext for his declaration of martial law.

Yoon declared martial law in December of 2024, citing legislative gridlock and what he described as a plot by pro-Pyongyang forces within the South Korean political establishment. The nation’s parliament formally overturned the decree within hours despite attempts by police and soldiers to stop lawmakers from accessing the National Assembly building.

Yoon was impeached just over a week later, suspended from office, and formally removed from power by the Constitutional Court months later.

On Friday, a Seoul court ruled that Yoon had abused his power and “benefited the enemy” with his drone plot, among other charges, and sentenced him to 30 years in prison. According to the Associated Press, the court also accused him of harming South Korea’s military interests by exposing its capabilities and prompting Pyongyang to take a stronger defensive posture.

Yoon’s former Defense Minister Kim Yong-hyun was also sentenced to 30 years in prison for his role in the plot, while former Defense Counterintelligence Command chief Yeo In-hyung received a 15-year sentence.

Friday’s sentence adds to Yoon’s growing list of convictions.

In February, he was sentenced to life after being convicted of attempting to orchestrate an insurrection and seize power. In April, an appeals court increased his sentence for abuse of authority and obstruction of duty.

Yoon’s downfall follows a long pattern of legal persecution of former South Korean leaders.

Four of his predecessors had received prison sentences after leaving office. Among them were Chun Doo-hwan, Roh Tae-woo, Lee Myung-bak and Park Geun-hye, although several were later pardoned.

June 12, 2026 Posted by | Civil Liberties, Deception, Militarism | | Comments Off on Ex-South Korean President sentenced for trying to provoke conflict with Pyongyang

US publishes docs on ‘dangerous’ Ukrainian biolabs

RT | June 12, 2026

US Director of National Intelligence (DNI) Tulsi Gabbard has released new evidence that US-funded biological laboratories in Ukraine were researching dangerous pathogens. Washington previously denied any role in running these labs.

Published on Friday, the declassified documents reveal that the US “built and supported” 40 biolabs in Ukraine, which worked with “especially dangerous pathogens” including anthrax, avian flu, Ebola, plague, and tuberculosis. At least 12 of these laboratories were carrying out human research.

Some of the laboratories were engaged in so-called ‘gain of function’ research, a controversial practice whereby animal viruses are modified to increase their virulence and transmissibility to study their effects on humans.

The partially-redacted documents state that the US paid for the construction and equipping of at least four laboratories, at a total cost of more than $9 million. They also reveal that these laboratories carried out research on behalf of and in collaboration with the US Department of Food and Agriculture, the US Army, the World Health Organization, the UN, and multiple US universities. Metabiota, a biotech company part-owned by Hunter Biden’s investment firm, is also listed as a partner.

What did Russia say about the biolabs?

As Russian troops entered Ukraine in February 2022, the Russian Defense Ministry claimed that Vladimir Zelensky’s government in Kiev ordered the “emergency destruction” of pathogens at multiple US-funded laboratories in Ukraine. The ministry accused Kiev of ordering the destruction in an attempt to hide its role in an American biological weapons program.

Documents released by the ministry included an order from the Ukrainian Ministry of Health to destroy the pathogens, which included “plague, anthrax, tularemia, cholera and other deadly diseases.”

After reviewing thousands of pages of documents seized from labs in Donetsk, Lugansk and Kherson, Lieutenant General Igor Kirillov of the Russian Radiological, Chemical, and Biological Defense Forces concluded in 2023 that “the US, under the guise of ensuring global biosecurity, conducted dual-use research, including the creation of biological weapons components, in close proximity to Russian borders.” Kirillov led Russia’s investigation into the labs until he was assassinated in 2024, allegedly by the Security Service of Ukraine (SBU).

Among the facilities mentioned by the ministry was the Institute of Veterinary Medicine in Kharkov. The Russian military accused Ukraine of researching potential biological weapons in the institute’s basement. According to Gabbard’s documents, the facility did have a basement level, where anthrax and brucella bacteria were stored. Both are considered bioweapons due to their extreme infectivity and capacity to cause debilitating illness.

Did the US deny that the biolabs existed?

Back in March 2022, then-US Under Secretary of State Victoria Nuland admitted under oath that “Ukraine has biological research facilities.” However, Nuland denied that these facilities worked on biological weapons, and insisted that “the United States does not own or operate any chemical or biological laboratories in Ukraine.”

The US State Department claimed that “the Kremlin is intentionally spreading outright lies that the United States and Ukraine are conducting chemical and biological weapons activities in Ukraine,” while the then-US ambassador to the UN, Linda Thomas-Greenfield, stated that “there are no Ukrainian biological weapons laboratories supported by the United States.”

What is Tulsi Gabbard doing about the biolabs?

“Despite the obvious potential for catastrophic global impact research on dangerous pathogens in biolabs can have, politicians, so-called health professionals like Dr. Fauci, and entities within the Biden administration’s national security team lied to the American people about the existence of US-funded and supported biolabs, and threatened those who attempted to expose the truth,” Gabbard said in a statement on Friday.

Gabbard said that she has issued new guidance to US intelligence agencies on collection of data from the laboratories in Ukraine, and from the broader network of US-linked biolabs around the world. At present, her office is collecting “new details on clinical trials that are underway at these facilities, raising significant ethical, financial, and security concerns,” her statement read.

However, Gabbard will not be in a position to act on this intelligence for much longer. Following her husband’s diagnosis with a rare form of bone cancer last month, Gabbard announced that she would retire at the end of June. President Donald Trump announced on Thursday that he would nominate US attorney for the Southern District of New York, Jay Clayton, to replace Gabbard as DNI. Clayton has never commented publicly on the biolabs issue.

June 12, 2026 Posted by | Deception, Militarism | , , | Comments Off on US publishes docs on ‘dangerous’ Ukrainian biolabs

Trump’s ERAM cruise missiles for Ukraine blow up his peace overtures to Russia

By Finian Cunningham | Strategic Culture Foundation | June 12, 2026

At the Anchorage summit last summer between U.S. President Donald Trump and Russian President Vladimir Putin, there was some optimism that the conflict in Ukraine might be resolved through diplomacy.

There appeared to be an atmosphere of bonhomie between the two leaders, and in particular, an openness on the American side to listen to Russia’s historic grievances about NATO’s enlargement, presenting a national security threat.

Only days later, however, Trump’s administration quietly approved the supply of new cruise missiles to Ukraine. After months of delay, those new types of weapons are now on their way to Ukraine. This firepower will give a deeper reach into Russia, which is already being assailed by long-range NATO drones.

The summit in the Alaskan capital in August 2025 was dubbed the “spirit of Anchorage.” The meeting was supposed to signal Trump’s commitment to finding a diplomatic settlement of the conflict, taking into account Russia’s historic territorial claims. There appeared to be a recognition on the American side of addressing Moscow’s concerns about the “root causes of conflict” from decades of NATO encroachment on its borders.

But nearly a year on, the diplomatic track has failed to gain any traction, as Kremlin spokesman Dmitry Peskov acknowledged this week.

Trump has, of course, become embroiled in a disastrous war against Iran, one that is endangering the whole Middle East and the global economy.

So much for the “peace presidency” that he had promised. Still, one might expect him to at least pay some token attention to pushing diplomacy in Ukraine. No. Like a kid bored with a new toy, Trump has backed away, which makes all his past angst to stop the slaughter in Ukraine something of a superficial theater.

What is still going ahead, though, is the supply of over 3,300 U.S.-made cruise weapons, manufactured under a program called the Extended Range Attack Missiles (ERAM). The ERAM program began production in April 2025 of two new cruise missile designs.

One weapon is called the Rapidly Adaptable Affordable Cruise Missile (RAACM), manufactured by CoAspire. It has a range of 450 kilometers.

The other design, known as Rusty Dagger, has a much longer range of over 900 km, and is produced by Zone Five Technologies. Both companies are based in the U.S.

The ERAMs are much smaller than Tomahawk cruise missiles in terms of overall size, weight, and explosive warhead. But they were engineered to give Ukraine a cheaper option for deep strikes in Russian territory. They also do not have the iconic image of the Tomahawk and, therefore, can be supplied without arousing the same provocation.

They are designed to be deployed as air-launched weapons using F-16 fighter jets or MiG-29s, both of which are flown by the Ukrainian armed forces.

European NATO states – Denmark, the Netherlands, and Norway – are picking up most of the tab for the $825 million cost of supplying the ERAMs to Ukraine, according to the Pentagon.

It is being reported, although not officially confirmed, that the Rusty Dagger ERAM, the longer-range version, has already begun operations in striking Russia. The claims are based on the alleged recovery of missile debris, showing navigation equipment belonging to Five Zone Technologies.

Since the Anchorage summit last year, President Trump has sought to cast the Kiev regime and the European NATO leaders as unhelpful to his efforts to make a peace deal with Russia. There has also been a belief on that Russian side that Trump is genuine in his expressions of wanting to find a diplomatic resolution to the more than four-year war in Ukraine – the biggest in Europe since World War II.

Moscow has tended to rebuke the Zelensky regime and its European patrons for being intransigent and acting to undermine Trump’s peace diplomacy. There is no doubt that this criticism of European Russophobia blocking diplomatic engagement has some merit.

Nevertheless, a reality check is due on what Washington’s abiding agenda is.

Washington has led the long-term strategic policy of confrontation with Russia using the NATO alliance and Ukraine as a proxy. This has been Washington’s systematic policy under successive U.S. administrations, from Clinton in the 1990s to Bush, Obama, Biden, and Trump.

It was under Trump during his first administration in 2018 that the U.S. broke the taboo of supplying lethal weapons to Ukraine. Those munitions included $47 million worth of Javelin anti-tank missiles. Russia warned at the time that such arming of Ukraine would lead to open conflict. That prediction duly culminated in February 2022 during the Biden administration when Russia invaded Ukraine to defend Russian-speaking people who were being attacked and killed by the NATO-backed NeoNazi Kiev regime.

Indeed, Trump has boasted at various times about how he was the first president to send lethal weapons to Ukraine, while at the same time trying to blame the Biden administration for starting the war.

In his second administration, from January 2025, Trump has balked at supplying Tomahawk cruise missiles to Ukraine so as not to provoke Russia after Moscow gave stern warnings against such a move. And he has talked up his supposed desire to end the slaughter, at one point claiming he could achieve that in 24 hours.

Trump has also scaled back sending U.S. tax dollars as military aid to Ukraine, which might suggest that he is serious about winding down the conflict.

A more nuanced view is that what transactional Trump seems more concerned about is not so much reducing the supply of U.S. weapons to Ukraine but rather getting the Europeans to pay for it.

This is evident from the expected supply of over 3,300 ERAM cruise missiles to Ukraine, which Europe is financing. Trump has approved that delivery.

Unmistakably, this represents a grave escalation in the war against Russia, whereby the U.S. and its European NATO partners are making a concerted effort to weaponize the Kiev regime to strike deeper. The new cruise missile arsenal dovetails with the ramping up of European-supplied and financed long-range drone capability.

Thus, the inescapable conclusion is that Washington’s agenda of hostility towards Russia has not changed fundamentally. It has merely become nuanced with duplicity about seeking diplomacy, a charade in which Washington is supposedly thwarted by a recalcitrant Kiev regime and European Russophobes.

This same duplicitous charade is played with regard to Iran. Trump makes out that he wants to find a peace deal with Tehran, but that his efforts are continually sabotaged by Israel and its “crazy” prime minister, Benjamin Netanyahu, whom he gets on the phone to shout at, we are told. This, from a U.S. president who started a war of aggression against Iran 100 days ago on February 28 by murdering Iran’s supreme leader while he was saying prayers in his Tehran home, and on the same day killing 168 schoolgirls in a multiple air strike on a college in Minab.

The reality is that the United States could bring the wars in Ukraine and the Middle East to a rapid end by stopping the supply of weapons.

Trump’s so-called peace diplomacy is a con to cover up for the fact that U.S. warmongering is the root cause of conflicts, and this warmongering is not going to stop until it is defeated.

June 12, 2026 Posted by | Deception, Militarism, Russophobia | , , , | Comments Off on Trump’s ERAM cruise missiles for Ukraine blow up his peace overtures to Russia

EU state lifts arms embargo on Israel after spy scandal

RT | June 12, 2026

Slovenian Prime Minister Janez Jansa has lifted an embargo on arms sales to Israel after allegedly enlisting the help of an Israeli private intelligence firm to oust his left-wing, pro-Palestine predecessor.

Jansa’s government announced the decision on Thursday, adding that it would also overturn an entry ban on Israeli Prime Minister Benjamin Netanyah, National Security Minister Itamar Ben Gvir, and Finance Minister Bezalel Smotrich.

“This will restore the conditions for a normal political dialog with Israel,” the Slovenian Defense Ministry said in a statement, adding that the move would help “strengthen the role of the Republic of Slovenia in the efforts to achieve a lasting peace in the Middle East.”

Former Slovenian Prime Minister Robert Golob barred the export of military goods to Israel and banned the import of goods from illegal Israeli settlements in the West Bank in August. One year earlier, he had recognized the State of Palestine and declared Israel’s war on Gaza to be “genocide.”

Last December, Jansa met with executives from Black Cube, an Israeli private intelligence firm founded by Israel Defense Forces intelligence veterans, whose advisory board includes two former Mossad directors. Three months later, and with parliamentary elections drawing near, covertly-recorded video footage emerged on social media, showing associates of Golob’s Svoboda party discussing corruption within the Slovenian government.

The videos, which Black Cube admitted to filming, weakened Golob’s standing ahead of the election, but Svoboda managed to beat Jansa’s Slovenian Democratic Party by a margin of 0.67%. However, Golob’s coalition lost its majority and was unable to form a government. Jansa, who served three previous stints as Slovenia’s prime minister, built a right-wing coalition and took office last week.

Slovenia’s Intelligence and Security Agency (SOVA) has since determined that Black Cube deliberately attempted to “influence democratic elections” by releasing the videos. “This interference was most likely commissioned from within Slovenia,” the agency concluded, without directly accusing Jansa of hiring the Israeli spies.

While it is unclear whether the Israeli government knew about or officially sanctioned Black Cube’s work in Slovenia, Israeli officials welcomed Jansa’s return to office and reversal of Golob’s policies.

“I commend Slovenian PM Janez Jansa for his swift and just decision to lift the distorted anti-Israeli measures taken by Slovenia’s previous government,” Israeli Foreign Minister Gideon Sa’ar wrote on X on Thursday, hailing Jansa as “a bold leader and a true friend of Israel.”

June 12, 2026 Posted by | Civil Liberties, Corruption, Deception, Ethnic Cleansing, Racism, Zionism | , , , | Comments Off on EU state lifts arms embargo on Israel after spy scandal

French watchdog reveals Israeli propaganda firm meddled in New York, Scottish, African elections

The Cradle | June 12, 2026

On 11 June, French disinformation and digital interference watchdog Viginum linked Israeli firm BlackCore to digital influence and propaganda campaigns across Europe, Africa, and the US.

Viginum Chief Marc-Antoine Brillant and French Prime Minister Sebastien Lecornu identified global operations in France, Scotland, Angola, Togo, and New York City.

“Our investigations did not make it possible to identify the sponsor or sponsors, if indeed they exist, behind this foreign digital interference,” Brillant told Reuters.

The report identified BlackCore-linked accounts targeting Scottish First Minister John Swinney, who has described Gaza as a “man-made humanitarian catastrophe.”

Earlier investigations by Viginum revealed that BlackCore had targeted hard-left France Unbowed party candidates in Marseille, Toulouse, and Roubaix using automated accounts and data leaks, as well as fabricated sexual violence allegations against some candidates.

The latest investigations suggest that in the US, the firm allegedly meddled in New York City municipal elections, which were won by Zohran Mamdani, with Brillant confirming the same “modus operandi” from the French campaigns was utilized, though it remains unclear who the specific targets were or who sponsored the operation.

While Mamdani’s victory was received positively by younger progressive members of the Jewish community in New York, traditional pro-Israel backers were unsettled by his outspoken support for Palestine.

Lecornu sought a formal diplomatic explanation from Israel, stating, “I do not doubt for a single instant that if a French private group, from French soil moreover, had engaged in foreign digital interference in Israel, they would have done the same to its ambassador on site.”

Reuters reported that BlackCore removed its entire online presence following inquiries from the news agency. The Israeli firm describes itself as “an elite influence, cyber, and technology company built for the modern era of information warfare.”

In early May, Israel had authorized an unprecedented $730 million propaganda budget for 2026, marking a fourfold increase with the aim of reversing the global decline in public perception following its genocide in Gaza, and the many aggressions towards its surrounding countries that followed.

Israeli Prime Minister Benjamin Netanyahu had designated this narrative offensive as the “Eighth Front” of the Israel’s various wars.

The operation functions as what analysts call a “Digital Iron Dome” designed to suppress dissenting online content through AI-driven surveillance and mass reporting while simultaneously flooding social media platforms with state-sponsored narratives.

Researchers have identified expanding state-backed efforts to shape global discourse through AI, paid influence, and covert campaigns.

In the US, millions of dollars were channeled through entities linked to US President Donald Trump to automate state-engineered narratives on social media and AI platforms like ChatGPT and Claude.

June 12, 2026 Posted by | Civil Liberties, Deception | , , , , , , | Comments Off on French watchdog reveals Israeli propaganda firm meddled in New York, Scottish, African elections

EU court adviser delivers another ‘Pfizergate’ blow to von der Leyen

RT | June 11, 2026

The European Commission should have revealed the details of its Covid-19 vaccine contracts with drugmakers to the public, an adviser to the EU’s highest court has declared. Among the contracts was a deal with Pfizer that commission President Ursula von der Leyen negotiated via text message.

In an opinion published on Thursday, Advocate General Athanasios Rantos argued that the commission’s insistence on secrecy made it impossible to know whether its vaccine negotiators had any conflicts of interest with the pharmaceutical companies that they procured the shots from.

The commission signed six advance purchase agreements with pharmaceutical companies – including Pfizer, AstraZeneca, and Moderna – between 2020 and 2021. The contracts were worth a combined €71 billion ($82 billion).

When Green MEPs and more than 3,000 members of the public demanded information about the negotiation process, the commission redacted the names of all of its negotiators and many of the contract clauses. The commission’s lawyers have argued that these redactions were made to protect the negotiators from “conspiracy theorists.”

The commission lost a legal battle to keep these details secret in 2024, but appealed the decision up to the Court of Justice of the European Union. Rantos’ opinion is not legally binding, but will inform the court’s final ruling.

Last year, the court ruled against von der Leyen in the ‘Pfizergate’ case, which centered around her negotiations with Pfizer CEO Albert Bourla. In 2021, von der Leyen told the New York Times that she had been negotiating a €35 billion deal for 900 million Covid vaccine doses with Bourla via sms messages.

The newspaper sued for access to the messages, arguing that von der Leyen could have used sms messaging to bypass EU transparency laws. The commission claimed that the messages had been lost, but the court ruled last May that the EU’s executive body failed to provide “credible explanations enabling the public and the Court to understand why those documents cannot be found.”

Von der Leyen survived a no-confidence vote initiated by right-wing parties in the European Parliament over the scandal last July.

June 11, 2026 Posted by | Corruption, Deception | , | Comments Off on EU court adviser delivers another ‘Pfizergate’ blow to von der Leyen